or, select a GWAS: β2-Glycoprotein I (β2-GPI) plasma levels (Athanasiadis G, 2013, 9 SNPs) 5-HTT brain serotonin transporter levels (Liu X, 2011, 1 SNP) Abdominal aortic aneurysm (4 SNPs from 3 studies) Abdominal aortic aneurysm (Bown MJ, 2011, 1 SNP) Abdominal aortic aneurysm (Bradley DT, 2013, 1 SNP) Abdominal aortic aneurysm (Gretarsdottir S, 2010, 2 SNPs) Acenocoumarol maintenance dosage (Teichert M, 2009, 4 SNPs) Acne (severe) (17 SNPs from 2 studies) Acne (severe) (He L, 2014, 3 SNPs) Acne (severe) (Navarini AA, 2014, 14 SNPs) Acoustic startle blink response (Vaidyanathan U, 2014, 6 SNPs) Activated partial thromboplastin time (9 SNPs from 2 studies) Activated partial thromboplastin time (Houlihan LM, 2010, 3 SNPs) Activated partial thromboplastin time (Tang W, 2012, 9 SNPs) Acute lymphoblastic leukemia (adolescents and young adults) (Perez-Andreu V, 2014, 1 SNP) Acute lymphoblastic leukemia (B-cell precursor) (Migliorini G, 2013, 6 SNPs) Acute lymphoblastic leukemia (childhood) (46 SNPs from 6 studies) Acute lymphoblastic leukemia (childhood) (Ellinghaus E, 2011, 31 SNPs) Acute lymphoblastic leukemia (childhood) (Evans TJ, 2014, 2 SNPs) Acute lymphoblastic leukemia (childhood) (Papaemmanuil E, 2009, 3 SNPs) Acute lymphoblastic leukemia (childhood) (Trevino LR, 2009, 14 SNPs) Acute lymphoblastic leukemia (childhood) (Xu H, 2013, 3 SNPs) Acute lymphoblastic leukemia (childhood) (Yang JJ, 2012, 10 SNPs) Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced) (Cornejo-Garcia JA, 2013, 9 SNPs) Addiction (Liu Z, 2013, 16 SNPs) Adiponectin levels (37 SNPs from 10 studies) Adiponectin levels (Chung CM, 2011, 1 SNP) Adiponectin levels (Dastani Z, 2012, 31 SNPs) Adiponectin levels (Heid IM, 2009, 1 SNP) Adiponectin levels (Jee SH, 2010, 1 SNP) Adiponectin levels (Ling H, 2009, 2 SNPs) Adiponectin levels (Morisaki H, 2011, 1 SNP) Adiponectin levels (Qi L, 2011, 5 SNPs) Adiponectin levels (Richards JB, 2009, 3 SNPs) Adiponectin levels (Wu Y, 2010, 3 SNPs) Adiponectin levels (Wu Y, 2013, 10 SNPs) Adiposity (8 SNPs from 3 studies) Adiposity (Kilpelainen TO, 2011, 3 SNPs) Adiposity (Lindgren CM, 2009, 4 SNPs) Adiposity (Plourde M, 2012, 1 SNP) Adolescent idiopathic scoliosis (severe) (Miyake A, 2013, 1 SNP) Adolescent idiopathic scoliosis (Sharma S, 2011, 1 SNP) Adverse response to aromatase inhibitors (Ingle JN, 2010, 1 SNP) Adverse response to carbamapezine (McCormack M, 2011, 1 SNP) Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil) (Low SK, 2013, 4 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs) (Low SK, 2013, 6 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs) (Low SK, 2013, 6 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs) (Low SK, 2013, 12 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs) (Low SK, 2013, 6 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors) (Low SK, 2013, 6 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin) (Low SK, 2013, 3 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin) (Low SK, 2013, 9 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin) (Low SK, 2013, 7 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide) (Low SK, 2013, 3 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel) (Low SK, 2013, 7 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin) (Low SK, 2013, 3 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) (Low SK, 2013, 5 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide) (Low SK, 2013, 4 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine) (Low SK, 2013, 5 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin) (Low SK, 2013, 7 SNPs) Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel) (Low SK, 2013, 8 SNPs) Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule) (Chung S, 2013, 7 SNPs) Adverse response to chemotherapy in breast cancer (alopecia) (Chung S, 2013, 3 SNPs) Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU) (Chung S, 2013, 8 SNPs) Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) (Chung S, 2013, 3 SNPs) Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel) (Chung S, 2013, 4 SNPs) Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel) (Chung S, 2013, 5 SNPs) Adverse response to lamotrigine and phenytoin (McCormack M, 2012, 12 SNPs) Adverse response to radiation therapy (Kerns SL, 2013, 3 SNPs) Age at smoking initiation in chronic obstructive pulmonary disease (Siedlinski M, 2011, 21 SNPs) Age of smoking initiation (Argos M, 2014, 8 SNPs) Age-related cataracts (age at onset) (Ritchie MD, 2014, 3 SNPs) Age-related cataracts (Ritchie MD, 2014, 3 SNPs) Age-related hearing impairment (Fransen E, 2014, 29 SNPs) Age-related macular degeneration (7 SNPs from 10 studies) Age-related macular degeneration (Arakawa S, 2011, 2 SNPs) Age-related macular degeneration (Chen W, 2010, 8 SNPs) Age-related macular degeneration (Cipriani V, 2012, 6 SNPs) Age-related macular degeneration (CNV vs. GA) (Sobrin L, 2012, 1 SNP) Age-related macular degeneration (CNV) (Sobrin L, 2012, 6 SNPs) Age-related macular degeneration (extreme sampling) (Naj AC, 2013, 3 SNPs) Age-related macular degeneration (Fritsche LG, 2013, 19 SNPs) Age-related macular degeneration (GA) (Sobrin L, 2012, 9 SNPs) Age-related macular degeneration (Holliday EG, 2013, 31 SNPs) Age-related macular degeneration (Klein RJ, 2005, 1 SNP) Age-related macular degeneration (Kopplin LJ, 2010, 4 SNPs) Age-related macular degeneration (Naj AC, 2013, 5 SNPs) Age-related macular degeneration (Neale BM, 2010, 11 SNPs) Age-related macular degeneration (smoking status interaction) (Naj AC, 2013, 3 SNPs) Age-related macular degeneration (wet) (Dewan A, 2006, 1 SNP) Age-related macular degeneration (Yu Y, 2011, 11 SNPs) Age-related nuclear cataracts (Liao J, 2014, 15 SNPs) Aggressive periodontitis (sex interaction) (Freitag-Wolf S, 2014, 1 SNP) Aging (9 SNPs from 2 studies) Aging (Edwards DR, 2012, 8 SNPs) Aging (facial) (Le Clerc S, 2012, 7 SNPs) Aging (Poduslo SE, 2009, 1 SNP) Aging (time to death) (Walter S, 2011, 3 SNPs) Aging (time to event) (Walter S, 2011, 8 SNPs) Aging traits (Lunetta KL, 2007, 10 SNPs) AIDS (Le Clerc S, 2009, 7 SNPs) AIDS progression (10 SNPs from 2 studies) AIDS progression (Limou S, 2009, 3 SNPs) AIDS progression (Troyer JL, 2011, 7 SNPs) Airflow obstruction (Wilk JB, 2012, 30 SNPs) Airway hyperresponsiveness (Himes BE, 2013, 1 SNP) Airway responsiveness in chronic obstructive pulmonary disease (Hansel NN, 2014, 26 SNPs) Airway wall thickness (Dijkstra AE, 2015, 19 SNPs) Alcohol and nictotine co-dependence (8 SNPs from 2 studies) Alcohol and nictotine co-dependence (Zuo L, 2012, 2 SNPs) Alcohol and nictotine co-dependence (Zuo L, 2012, 8 SNPs) Alcohol consumption (21 SNPs from 4 studies) Alcohol consumption (Baik I, 2011, 4 SNPs) Alcohol consumption (Kapoor M, 2013, 15 SNPs) Alcohol consumption (maxi-drinks) (Quillen EE, 2013, 3 SNPs) Alcohol consumption (McGue M, 2013, 2 SNPs) Alcohol consumption (Schumann G, 2011, 1 SNP) Alcohol consumption (transferrin glycosylation) (Kutalik Z, 2011, 6 SNPs) Alcohol dependence (25 SNPs from 10 studies) Alcohol dependence (age at onset) (Kapoor M, 2014, 26 SNPs) Alcohol dependence (Frank J, 2011, 6 SNPs) Alcohol dependence (Kendler KS, 2011, 3 SNPs) Alcohol dependence (Lydall GJ, 2011, 1 SNP) Alcohol dependence (McGue M, 2013, 4 SNPs) Alcohol dependence (Park BL, 2013, 1 SNP) Alcohol dependence (Quillen EE, 2013, 2 SNPs) Alcohol dependence (Treutlein J, 2009, 6 SNPs) Alcohol dependence (Wang KS, 2011, 2 SNPs) Alcohol dependence (Zuo L, 2011, 3 SNPs) Alcohol dependence (Zuo L, 2013, 1 SNP) Alcoholism (12-month weekly alcohol consumption) (Heath AC, 2011, 2 SNPs) Alcoholism (alcohol dependence factor score) (Heath AC, 2011, 6 SNPs) Alcoholism (alcohol use disorder factor score) (Heath AC, 2011, 6 SNPs) Alcoholism (heaviness of drinking) (Heath AC, 2011, 8 SNPs) Allergic dermatitis (nickel) (Kim DS, 2013, 2 SNPs) Allergic rhinitis (35 SNPs from 2 studies) Allergic rhinitis (Bunyavanich S, 2014, 26 SNPs) Allergic rhinitis (Ramasamy A, 2011, 9 SNPs) Allergic rhinitis in asthma (Bunyavanich S, 2014, 1 SNP) Allergic rhinitis in non-asthmatics (Bunyavanich S, 2014, 7 SNPs) Allergic sensitization (Bonnelykke K, 2013, 12 SNPs) Alloimmunization response to red blood cell transfusion in sickle cell anemia (Hanchard NA, 2014, 1 SNP) Alopecia areata (Petukhova L, 2010, 8 SNPs) Alzheimer's disease (45 SNPs from 20 studies) Alzheimer's disease (Abraham R, 2008, 2 SNPs) Alzheimer's disease (age of onset) (Kamboh MI, 2011, 13 SNPs) Alzheimer's disease (Antunez C, 2011, 5 SNPs) Alzheimer's disease (Beecham GW, 2009, 3 SNPs) Alzheimer's disease (Bertram L, 2008, 2 SNPs) Alzheimer's disease (Carrasquillo MM, 2009, 1 SNP) Alzheimer's disease (cognitive decline) (Sherva R, 2013, 44 SNPs) Alzheimer's disease (Feulner TM, 2009, 1 SNP) Alzheimer's disease (Harold D, 2009, 3 SNPs) Alzheimer's disease (Heinzen EL, 2009, 5 SNPs) Alzheimer's disease (Hollingworth P, 2011, 4 SNPs) Alzheimer's disease (Jonsson T, 2012, 1 SNP) Alzheimer's disease (Kamboh MI, 2012, 8 SNPs) Alzheimer's disease (Kramer PL, 2010, 2 SNPs) Alzheimer's disease (Lambert JC, 2009, 6 SNPs) Alzheimer's disease (Lambert JC, 2012, 3 SNPs) Alzheimer's disease (late onset) (50 SNPs from 10 studies) Alzheimer's disease (late onset) (Coon KD, 2007, 1 SNP) Alzheimer's disease (late onset) (Cummings AC, 2012, 13 SNPs) Alzheimer's disease (late onset) (European Alzheimer's Disease Initiative (EADI), 2013, 32 SNPs) Alzheimer's disease (late onset) (Hu X, 2011, 2 SNPs) Alzheimer's disease (late onset) (Miyashita A, 2013, 2 SNPs) Alzheimer's disease (late onset) (Naj AC, 2010, 4 SNPs) Alzheimer's disease (late onset) (Naj AC, 2011, 9 SNPs) Alzheimer's disease (late onset) (Reiman EM, 2007, 1 SNP) Alzheimer's disease (late onset) (Reitz C, 2013, 2 SNPs) Alzheimer's disease (late onset) (Wijsman EM, 2011, 1 SNP) Alzheimer's disease (Li H, 2007, 1 SNP) Alzheimer's disease (Logue MW, 2011, 11 SNPs) Alzheimer's disease (Nelson PT, 2014, 3 SNPs) Alzheimer's disease (Perez-Palma E, 2014, 5 SNPs) Alzheimer's disease (Seshadri S, 2010, 1 SNP) Alzheimer's disease (Webster JA, 2007, 1 SNP) Alzheimer's disease biomarkers (16 SNPs from 3 studies) Alzheimer's disease biomarkers (Cruchaga C, 2013, 6 SNPs) Alzheimer's disease biomarkers (Kim S, 2010, 7 SNPs) Alzheimer's disease biomarkers (Ramanan VK, 2013, 12 SNPs) Amyloid A serum levels (Marzi C, 2010, 4 SNPs) Amyotrophic lateral sclerosis (55 SNPs from 13 studies) Amyotrophic lateral sclerosis (age of onset) (Ahmeti KB, 2012, 13 SNPs) Amyotrophic lateral sclerosis (Ahmeti KB, 2012, 15 SNPs) Amyotrophic lateral sclerosis (Cronin S, 2007, 1 SNP) Amyotrophic lateral sclerosis (Cronin S, 2008, 1 SNP) Amyotrophic lateral sclerosis (Deng M, 2013, 2 SNPs) Amyotrophic lateral sclerosis (Diekstra FP, 2014, 6 SNPs) Amyotrophic lateral sclerosis (Kwee LC, 2012, 2 SNPs) Amyotrophic lateral sclerosis (Laaksovirta H, 2010, 2 SNPs) Amyotrophic lateral sclerosis (Landers JE, 2009, 16 SNPs) Amyotrophic lateral sclerosis (Schymick JC, 2007, 6 SNPs) Amyotrophic lateral sclerosis (Shatunov A, 2010, 6 SNPs) Amyotrophic lateral sclerosis (sporadic) (95 SNPs from 2 studies) Amyotrophic lateral sclerosis (sporadic) (Fogh I, 2013, 4 SNPs) Amyotrophic lateral sclerosis (sporadic) (Xie T, 2014, 91 SNPs) Amyotrophic lateral sclerosis (van Es MA, 2007, 1 SNP) Amyotrophic lateral sclerosis (van Es MA, 2007, 3 SNPs) Amyotrophic lateral sclerosis (van Es MA, 2009, 8 SNPs) Amyotrophic lateral sclerosis or frontotemporal dementia (Diekstra FP, 2014, 1 SNP) Androgen levels (Jin G, 2012, 6 SNPs) Anger (Mick E, 2014, 14 SNPs) Angiotensin-converting enzyme activity (Chung CM, 2010, 2 SNPs) Ankle-brachial index (Murabito JM, 2011, 2 SNPs) Ankylosing spondylitis (21 SNPs from 3 studies) Ankylosing spondylitis (Evans DM, 2011, 13 SNPs) Ankylosing spondylitis (Lin Z, 2011, 5 SNPs) Ankylosing spondylitis (Reveille JD, 2010, 9 SNPs) Anorexia nervosa (26 SNPs from 3 studies) Anorexia nervosa (Boraska V, 2014, 2 SNPs) Anorexia nervosa (Wade TD, 2013, 15 SNPs) Anorexia nervosa (Wang K, 2010, 9 SNPs) Anterior chamber depth (Nongpiur ME, 2014, 1 SNP) Anthropometric traits (Polasek O, 2009, 13 SNPs) Anthropometric traits in newborns (Urbanek M, 2013, 5 SNPs) Anti-cyclic Citrullinated Peptide Antibody (Cui J, 2009, 1 SNP) Anti-saccade response (Vaidyanathan U, 2014, 5 SNPs) Antibody status in Tripanosoma cruzi seropositivity (Deng X, 2013, 20 SNPs) Anticoagulant levels (Athanasiadis G, 2011, 8 SNPs) Antineutrophil cytoplasmic antibody-associated vasculitis (Lyons PA, 2012, 18 SNPs) Antinuclear antibody levels (Terao C, 2014, 1 SNP) Antipsychotic drug-induced weight gain (Malhotra AK, 2012, 1 SNP) Antipsychotic-induced QTc interval prolongation (Aberg K, 2010, 3 SNPs) Anxiety and major depressive disorder (Schosser A, 2013, 3 SNPs) Anxiety disorder (Otowa T, 2014, 15 SNPs) Anxiety in major depressive disorder (Schosser A, 2013, 8 SNPs) Aortic root size (13 SNPs from 2 studies) Aortic root size (Vasan RS, 2009, 6 SNPs) Aortic root size (Wineinger NE, 2011, 7 SNPs) Aortic stiffness (Mitchell GF, 2011, 1 SNP) Aortic-valve calcification (Thanassoulis G, 2013, 1 SNP) Apolipoprotein Levels (Surakka I, 2012, 3 SNPs) Arsenic metabolism (Pierce BL, 2012, 2 SNPs) Arterial stiffness (Tarasov KV, 2009, 1 SNP) Arthritis (juvenile idiopathic) (6 SNPs from 3 studies) Arthritis (juvenile idiopathic) (Behrens EM, 2008, 1 SNP) Arthritis (juvenile idiopathic) (Hinks A, 2009, 1 SNP) Arthritis (juvenile idiopathic) (Thompson SD, 2012, 4 SNPs) Asparaginase hypersensitivity in acute lymphoblastic leukemia (Chen SH, 2010, 1 SNP) Aspartate aminotransferase (Shen H, 2011, 1 SNP) Asperger disorder (Salyakina D, 2010, 5 SNPs) Aspirin exacerbated respiratory disease in asthmatics (Park BL, 2012, 1 SNP) Aspirin hydrolysis (plasma) (Zhou G, 2013, 1 SNP) Asthma (34 SNPs from 14 studies) Asthma (bronchodilator response) (3 SNPs from 2 studies) Asthma (bronchodilator response) (Duan QL, 2013, 2 SNPs) Asthma (bronchodilator response) (Himes BE, 2012, 1 SNP) Asthma (childhood onset) (31 SNPs from 4 studies) Asthma (childhood onset) (Bonnelykke K, 2013, 6 SNPs) Asthma (childhood onset) (Ding L, 2013, 19 SNPs) Asthma (childhood onset) (Forno E, 2012, 5 SNPs) Asthma (childhood onset) (Hancock DB, 2009, 1 SNP) Asthma (corticosteroid response) (Park HW, 2014, 2 SNPs) Asthma (Ferreira MA, 2010, 1 SNP) Asthma (Ferreira MA, 2011, 4 SNPs) Asthma (Himes BE, 2009, 1 SNP) Asthma (Hirota T, 2011, 14 SNPs) Asthma (Lasky-Su J, 2012, 1 SNP) Asthma (Li X, 2010, 3 SNPs) Asthma (Moffatt MF, 2007, 1 SNP) Asthma (Moffatt MF, 2010, 10 SNPs) Asthma (Noguchi E, 2011, 2 SNPs) Asthma (Ramasamy A, 2012, 2 SNPs) Asthma (sex interaction) (Myers RA, 2014, 6 SNPs) Asthma (Sleiman PM, 2009, 1 SNP) Asthma (Tantisira KG, 2012, 1 SNP) Asthma (toluene diisocyanate-induced) (Kim SH, 2009, 3 SNPs) Asthma (Torgerson DG, 2011, 7 SNPs) Asthma (Wan YI, 2012, 6 SNPs) Asthma and hay fever (Ferreira MA, 2013, 21 SNPs) Asthma or chronic obstructive pulmonary disease (Smolonska J, 2014, 3 SNPs) Asymmetrical dimethylarginine levels (21 SNPs from 2 studies) Asymmetrical dimethylarginine levels (Luneburg N, 2014, 1 SNP) Asymmetrical dimethylarginine levels (Seppala I, 2013, 21 SNPs) Atopic dermatitis (21 SNPs from 5 studies) Atopic dermatitis (Esparza-Gordillo J, 2009, 1 SNP) Atopic dermatitis (Hirota T, 2012, 17 SNPs) Atopic dermatitis (Paternoster L, 2011, 6 SNPs) Atopic dermatitis (Sun LD, 2011, 1 SNP) Atopic dermatitis (Weidinger S, 2013, 4 SNPs) Atopy (Castro-Giner F, 2009, 1 SNP) Atrial fibrillation (15 SNPs from 5 studies) Atrial fibrillation (Benjamin EJ, 2009, 3 SNPs) Atrial fibrillation (Ellinor PT, 2010, 3 SNPs) Atrial fibrillation (Ellinor PT, 2012, 10 SNPs) Atrial fibrillation (Gudbjartsson DF, 2009, 2 SNPs) Atrial fibrillation (Larson MG, 2007, 3 SNPs) Atrial fibrillation/atrial flutter (Gudbjartsson DF, 2007, 2 SNPs) Atrioventricular conduction (Denny JC, 2010, 5 SNPs) Attention deficit hyperactivity disorder (74 SNPs from 8 studies) Attention deficit hyperactivity disorder (combined symptoms) (Ebejer JL, 2013, 21 SNPs) Attention deficit hyperactivity disorder (Hinney A, 2011, 2 SNPs) Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms) (Ebejer JL, 2013, 25 SNPs) Attention deficit hyperactivity disorder (inattention symptoms) (Ebejer JL, 2013, 22 SNPs) Attention deficit hyperactivity disorder (Lasky-Su J, 2008, 19 SNPs) Attention deficit hyperactivity disorder (Lesch KP, 2008, 26 SNPs) Attention deficit hyperactivity disorder (Mick E, 2008, 2 SNPs) Attention deficit hyperactivity disorder (Mick E, 2010, 10 SNPs) Attention deficit hyperactivity disorder (Mick E, 2011, 7 SNPs) Attention deficit hyperactivity disorder (Neale BM, 2010, 5 SNPs) Attention deficit hyperactivity disorder (time to onset) (Lasky-Su J, 2008, 11 SNPs) Attention deficit hyperactivity disorder (Yang L, 2013, 4 SNPs) Attention deficit hyperactivity disorder and conduct disorder (Anney RJ, 2008, 26 SNPs) Attention deficit hyperactivity disorder motor coordination (Fliers EA, 2011, 1 SNP) Attention deficit hyperactivity disorder symptoms (interaction) (Sonuga-Barke EJ, 2008, 7 SNPs) Autism (51 SNPs from 6 studies) Autism (Anney R, 2010, 2 SNPs) Autism (Anney R, 2012, 4 SNPs) Autism (Ma D, 2009, 1 SNP) Autism (Wang K, 2009, 1 SNP) Autism (Weiss LA, 2009, 1 SNP) Autism (Xia K, 2013, 43 SNPs) Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) (Smoller JW, 2013, 74 SNPs) Autism spectrum disorder-related traits (Chaste P, 2014, 6 SNPs) Autoimmune hepatitis type-1 (de Boer YS, 2014, 3 SNPs) Axial length (Cheng CY, 2013, 21 SNPs) B cell non-Hodgkin lymphoma (Tan DE, 2013, 1 SNP) B-type natriuretic peptide (Musani SK, 2015, 2 SNPs) Barrett's esophagus (12 SNPs from 2 studies) Barrett's esophagus (Levine DM, 2013, 7 SNPs) Barrett's esophagus (Su Z, 2012, 5 SNPs) Basal cell carcinoma (14 SNPs from 5 studies) Basal cell carcinoma (Nan H, 2011, 3 SNPs) Basal cell carcinoma (Rafnar T, 2009, 1 SNP) Basal cell carcinoma (Stacey SN, 2008, 2 SNPs) Basal cell carcinoma (Stacey SN, 2011, 1 SNP) Basal cell carcinoma (Stacey SN, 2014, 11 SNPs) Behavioural disinhibition (generation interaction) (McGue M, 2013, 20 SNPs) Behcet's disease (12 SNPs from 4 studies) Behcet's disease (Hou S, 2012, 8 SNPs) Behcet's disease (Kirino Y, 2013, 6 SNPs) Behcet's disease (Mizuki N, 2010, 2 SNPs) Behcet's disease (Remmers EF, 2010, 2 SNPs) Beta thalassemia/hemoglobin E disease (Nuinoon M, 2009, 3 SNPs) Beta-2 microglubulin plasma levels (Tin A, 2013, 7 SNPs) Beta-trace protein levels (Tin A, 2013, 1 SNP) Biliary atresia (Garcia-Barcelo MM, 2010, 3 SNPs) Bilirubin levels (28 SNPs from 7 studies) Bilirubin levels (Bielinski SJ, 2011, 5 SNPs) Bilirubin levels (Chen G, 2011, 9 SNPs) Bilirubin levels (Cox AJ, 2013, 1 SNP) Bilirubin levels (Dai X, 2013, 10 SNPs) Bilirubin levels (Johnson AD, 2009, 8 SNPs) Bilirubin levels (Kang TW, 2010, 14 SNPs) Bilirubin levels (Sanna S, 2009, 3 SNPs) Bilirubin levels in extreme obesity (DiStefano JK, 2014, 1 SNP) Binge eating behaviour and bipolar disorder (Winham SJ, 2014, 2 SNPs) Binge eating behaviour in bipolar disorder (Winham SJ, 2014, 1 SNP) Biochemical measures (Zemunik T, 2009, 17 SNPs) Biomedical quantitative traits (Cho YS, 2009, 8 SNPs) Bipolar disorder (95 SNPs from 15 studies) Bipolar disorder (age of onset and psychotic symptoms) (Belmonte Mahon P, 2011, 2 SNPs) Bipolar disorder (Baum AE, 2007, 1 SNP) Bipolar disorder (Bergen SE, 2012, 4 SNPs) Bipolar disorder (body mass index interaction) (Winham SJ, 2013, 51 SNPs) Bipolar disorder (Chen DT, 2011, 5 SNPs) Bipolar disorder (Cichon S, 2011, 1 SNP) Bipolar disorder (Ferreira MA, 2008, 21 SNPs) Bipolar disorder (Jiang Y, 2011, 24 SNPs) Bipolar disorder (Kerner B, 2011, 3 SNPs) Bipolar disorder (Lee HJ, 2012, 20 SNPs) Bipolar disorder (mania) (Greenwood TA, 2013, 1 SNP) Bipolar disorder (Mühleisen, 2014, 6 SNPs) Bipolar disorder (Scott LJ, 2009, 13 SNPs) Bipolar disorder (Sklar P, 2011, 18 SNPs) Bipolar disorder (Smith EN, 2009, 1 SNP) Bipolar disorder (Smith EN, 2011, 6 SNPs) Bipolar disorder (WTCCC, 2007, 7 SNPs) Bipolar disorder (Yosifova A, 2011, 3 SNPs) Bipolar disorder and major depressive disorder (combined) (Liu Y, 2010, 9 SNPs) Bipolar disorder and schizophrenia (121 SNPs from 3 studies) Bipolar disorder and schizophrenia (Bergen SE, 2012, 13 SNPs) Bipolar disorder and schizophrenia (Curtis D, 2010, 6 SNPs) Bipolar disorder and schizophrenia (Wang KS, 2010, 103 SNPs) Bipolar disorder with mood-incongruent psychosis (Goes FS, 2012, 16 SNPs) Bipolar I disorder (Lee MT, 2010, 2 SNPs) Birdshot chorioretinopathy (Kuiper JJ, 2014, 2 SNPs) Birth length (van der Valk RJ, 2014, 6 SNPs) Birth weight (11 SNPs from 3 studies) Birth weight (Freathy RM, 2010, 2 SNPs) Birth weight (Horikoshi M, 2012, 10 SNPs) Birth weight (Metrustry SJ, 2014, 1 SNP) Bitter taste perception (Ledda M, 2013, 3 SNPs) Bitter taste response (Reed DR, 2010, 1 SNP) Black vs. blond hair color (Han J, 2008, 7 SNPs) Black vs. red hair color (Han J, 2008, 7 SNPs) Bladder cancer (19 SNPs from 6 studies) Bladder cancer (Figueroa JD, 2013, 17 SNPs) Bladder cancer (Garcia-Closas M, 2011, 1 SNP) Bladder cancer (Matsuda K, 2014, 1 SNP) Bladder cancer (Rafnar T, 2011, 1 SNP) Bladder cancer (Rothman N, 2010, 9 SNPs) Bladder cancer (smoking interaction) (Figueroa JD, 2014, 5 SNPs) Bladder cancer (Wu X, 2009, 1 SNP) Bleomycin sensitivity (Gu J, 2010, 3 SNPs) Blond vs. brown hair color (5 SNPs from 2 studies) Blond vs. brown hair color (Sulem P, 2007, 4 SNPs) Blond vs. brown hair color (Sulem P, 2008, 1 SNP) Blood and toenail selenium levels (Cornelis MC, 2014, 12 SNPs) Blood metabolite levels (Shin SY, 2014, 245 SNPs) Blood metabolite ratios (Shin SY, 2014, 54 SNPs) Blood pressure (86 SNPs from 8 studies) Blood pressure (age interaction) (Simino J, 2014, 3 SNPs) Blood pressure (anthropometric measures interaction) (Kim YK, 2014, 2 SNPs) Blood pressure (Franceschini N, 2013, 11 SNPs) Blood pressure (Kato N, 2011, 17 SNPs) Blood pressure (Kelly TN, 2013, 6 SNPs) Blood pressure (Levy D, 2007, 9 SNPs) Blood pressure (Simino J, 2014, 28 SNPs) Blood pressure (smoking interaction) (Sung YJ, 2014, 37 SNPs) Blood pressure (Wain LV, 2011, 41 SNPs) Blood pressure (Wang Y, 2008, 1 SNP) Blood pressure (Zhang D, 2012, 4 SNPs) Blood pressure measurement (cold pressor test) (He J, 2013, 7 SNPs) Blood pressure measurement (high sodium and potassium intervention) (He J, 2013, 11 SNPs) Blood pressure measurement (high sodium intervention) (He J, 2013, 9 SNPs) Blood pressure measurement (low sodium intervention) (He J, 2013, 10 SNPs) Blood trace element (Cu levels) (Evans DM, 2013, 7 SNPs) Blood trace element (Se levels) (Evans DM, 2013, 10 SNPs) Blood trace element (Zn levels) (Evans DM, 2013, 11 SNPs) Blue vs. brown eyes (Sulem P, 2007, 1 SNP) Blue vs. green eyes (4 SNPs from 2 studies) Blue vs. green eyes (Sulem P, 2007, 3 SNPs) Blue vs. green eyes (Sulem P, 2008, 1 SNP) Body mass (lean) (2 SNPs from 2 studies) Body mass (lean) (Guo YF, 2012, 1 SNP) Body mass (lean) (Liu XG, 2009, 1 SNP) Body mass in chronic obstructive pulmonary disease (Wan ES, 2010, 1 SNP) Body mass index (95 SNPs from 22 studies) Body mass index (Berndt SI, 2013, 10 SNPs) Body mass index (change over time) (10 SNPs from 2 studies) Body mass index (change over time) (McQueen MB, 2014, 4 SNPs) Body mass index (change over time) (Scannell Bryan M, 2014, 6 SNPs) Body mass index (Croteau-Chonka DC, 2010, 6 SNPs) Body mass index (education interaction) (Boardman JD, 2013, 3 SNPs) Body mass index (Fox CS, 2007, 3 SNPs) Body mass index (Frayling TM, 2007, 1 SNP) Body mass index (Graff M, 2013, 14 SNPs) Body mass index (interaction) (Velez Edwards DR, 2012, 15 SNPs) Body mass index (Johansson A, 2009, 10 SNPs) Body mass index (Liu JZ, 2010, 2 SNPs) Body mass index (Loos RJ, 2008, 2 SNPs) Body mass index (Monda KL, 2013, 7 SNPs) Body mass index (Namjou B, 2013, 8 SNPs) Body mass index (Ng MC, 2011, 2 SNPs) Body mass index (Okada Y, 2012, 10 SNPs) Body mass index (Pei YF, 2013, 3 SNPs) Body mass index (Scannell Bryan M, 2014, 4 SNPs) Body mass index (Speliotes EK, 2010, 38 SNPs) Body mass index (Thorleifsson G, 2008, 14 SNPs) Body mass index (Wang KS, 2012, 3 SNPs) Body mass index (Wen W, 2012, 7 SNPs) Body mass index (Wen W, 2014, 25 SNPs) Body mass index (Willer CJ, 2008, 11 SNPs) Body mass index (Yang F, 2014, 2 SNPs) Body mass index (Yang J, 2012, 1 SNP) Body mass index and cholesterol (psychopharmacological treatment) (Athanasiu L, 2012, 2 SNPs) Body mass index in asthmatics (Melen E, 2013, 6 SNPs) Body mass index in non-asthmatics (Melen E, 2013, 9 SNPs) Bone mineral density (68 SNPs from 14 studies) Bone mineral density (Duncan EL, 2011, 9 SNPs) Bone mineral density (Estrada K, 2012, 69 SNPs) Bone mineral density (Guo Y, 2009, 2 SNPs) Bone mineral density (hip) (17 SNPs from 3 studies) Bone mineral density (hip) (Rivadeneira F, 2009, 13 SNPs) Bone mineral density (hip) (Styrkarsdottir U, 2008, 6 SNPs) Bone mineral density (hip) (Styrkarsdottir U, 2008, 8 SNPs) Bone mineral density (Kiel DP, 2007, 8 SNPs) Bone mineral density (Kung AW, 2010, 1 SNP) Bone mineral density (Medina-Gomez C, 2012, 2 SNPs) Bone mineral density (paediatric, lower limb) (Kemp JP, 2014, 11 SNPs) Bone mineral density (paediatric, skull) (Kemp JP, 2014, 19 SNPs) Bone mineral density (paediatric, total body less head) (Kemp JP, 2014, 15 SNPs) Bone mineral density (paediatric, upper limb) (Kemp JP, 2014, 11 SNPs) Bone mineral density (Paternoster L, 2010, 1 SNP) Bone mineral density (Paternoster L, 2013, 7 SNPs) Bone mineral density (Richards JB, 2008, 2 SNPs) Bone mineral density (spine) (20 SNPs from 3 studies) Bone mineral density (spine) (Rivadeneira F, 2009, 16 SNPs) Bone mineral density (spine) (Styrkarsdottir U, 2008, 7 SNPs) Bone mineral density (spine) (Styrkarsdottir U, 2008, 8 SNPs) Bone mineral density (Styrkarsdottir U, 2013, 1 SNP) Bone mineral density (wrist) (Tan L, 2010, 1 SNP) Bone mineral density (Xiong DH, 2009, 2 SNPs) Bone mineral density (Zhang L, 2013, 24 SNPs) Bone mineral density (Zheng HF, 2012, 1 SNP) Bone mineral density (Zheng HF, 2013, 1 SNP) Bone properties (heel) (Moayyeri A, 2014, 20 SNPs) Borderline personality disorder features (Lubke GH, 2013, 1 SNP) Brachial circumference (Boraska V, 2012, 1 SNP) Brain connectivity (Jahanshad N, 2013, 12 SNPs) Brain cytoarchitecture (Kim S, 2010, 2 SNPs) Brain imaging (Shen L, 2010, 10 SNPs) Brain imaging in schizophrenia (interaction) (Potkin SG, 2008, 6 SNPs) Brain lesion load (Baranzini SE, 2008, 4 SNPs) Brain structure (21 SNPs from 2 studies) Brain structure (hippocampal volume) (Stein JL, 2010, 4 SNPs) Brain structure (Stein JL, 2010, 19 SNPs) Brain structure (Stein JL, 2012, 2 SNPs) Brain structure (temporal lobe volume) (Stein JL, 2010, 5 SNPs) Breast cancer (114 SNPs from 29 studies) Breast cancer (Antoniou AC, 2010, 1 SNP) Breast cancer (Cai Q, 2011, 2 SNPs) Breast cancer (Cai Q, 2014, 4 SNPs) Breast cancer (Chen F, 2012, 1 SNP) Breast cancer (early onset) (Ahsan H, 2014, 18 SNPs) Breast cancer (Easton DF, 2007, 6 SNPs) Breast cancer (Elgazzar S, 2012, 2 SNPs) Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative) (Purrington KS, 2013, 5 SNPs) Breast cancer (Fejerman L, 2014, 2 SNPs) Breast cancer (Fletcher O, 2011, 9 SNPs) Breast cancer (Garcia-Closas M, 2013, 17 SNPs) Breast cancer (Gold B, 2008, 1 SNP) Breast cancer (Haiman CA, 2011, 1 SNP) Breast cancer (Haryono SJ, 2015, 2 SNPs) Breast cancer (Hunter DJ, 2007, 1 SNP) Breast cancer (Kibriya MG, 2008, 1 SNP) Breast cancer (Kim HC, 2012, 1 SNP) Breast cancer (Li J, 2010, 4 SNPs) Breast cancer (Long J, 2010, 1 SNP) Breast cancer (Long J, 2012, 3 SNPs) Breast cancer (Low SK, 2013, 4 SNPs) Breast cancer (male) (Orr N, 2012, 3 SNPs) Breast cancer (menopausal hormone therapy interaction) (Rudolph A, 2013, 2 SNPs) Breast cancer (Michailidou K, 2013, 63 SNPs) Breast cancer (Murabito JM, 2007, 9 SNPs) Breast cancer (prognosis) (Rafiq S, 2013, 5 SNPs) Breast cancer (Rinella ES, 2013, 3 SNPs) Breast cancer (Sehrawat B, 2011, 2 SNPs) Breast cancer (Siddiq A, 2012, 4 SNPs) Breast cancer (Song C, 2013, 33 SNPs) Breast cancer (Stacey SN, 2007, 2 SNPs) Breast cancer (survival) (6 SNPs from 2 studies) Breast cancer (survival) (Rafiq S, 2014, 3 SNPs) Breast cancer (survival) (Shu XO, 2012, 3 SNPs) Breast cancer (Thomas G, 2009, 6 SNPs) Breast cancer (Turnbull C, 2010, 13 SNPs) Breast cancer (Zheng W, 2009, 1 SNP) Breast Cancer in BRCA1 mutation carriers (Couch FJ, 2013, 6 SNPs) Breast cancer in BRCA2 mutation carriers (Gaudet MM, 2010, 1 SNP) Breast size (Eriksson N, 2012, 31 SNPs) Breastfeeding duration (Colodro-Conde L, 2014, 9 SNPs) Bronchodilator response in asthma (inhaled corticosteroid treatment interaction) (Wu AC, 2013, 5 SNPs) Bronchodilator response in asthma (Israel E, 2015, 1 SNP) Bronchopulmonary dysplasia (Wang H, 2013, 26 SNPs) Brugada syndrome (Bezzina CR, 2013, 3 SNPs) Bulimia nervosa (Wade TD, 2013, 23 SNPs) Burning and freckling (Sulem P, 2008, 2 SNPs) Butyrylcholinesterase levels (Benyamin B, 2011, 3 SNPs) C-reactive protein (12 SNPs from 8 studies) C-reactive protein (Dorajoo R, 2013, 4 SNPs) C-reactive protein (Doumatey AP, 2012, 1 SNP) C-reactive protein (Elliott P, 2009, 5 SNPs) C-reactive protein (Okada Y, 2010, 4 SNPs) C-reactive protein (Reiner AP, 2008, 3 SNPs) C-reactive protein (Reiner AP, 2012, 11 SNPs) C-reactive protein (Ridker PM, 2008, 7 SNPs) C-reactive protein (Wu Y, 2011, 3 SNPs) C-reactive protein and white blood cell count (Kong M, 2012, 9 SNPs) C-reactive protein levels (23 SNPs from 2 studies) C-reactive protein levels (Dehghan A, 2011, 20 SNPs) C-reactive protein levels (Vinayagamoorthy N, 2014, 5 SNPs) C4b binding protein levels (Buil A, 2010, 1 SNP) Caffeine consumption (Cornelis MC, 2011, 10 SNPs) Calcium levels (17 SNPs from 3 studies) Calcium levels (Kapur K, 2010, 1 SNP) Calcium levels (O'Seaghdha CM, 2010, 10 SNPs) Calcium levels (O'Seaghdha CM, 2013, 13 SNPs) Callous-unemotional behaviour (Viding E, 2013, 3 SNPs) Cannabis dependence (Agrawal A, 2010, 10 SNPs) Cannabis use (initiation) (Verweij KJ, 2012, 6 SNPs) Capecitabine sensitivity (O'Donnell PH, 2012, 22 SNPs) Cardiac hypertrophy (Parsa A, 2011, 19 SNPs) Cardiac muscle measurement (Arnett DK, 2011, 3 SNPs) Cardiac repolarization (4 SNPs from 2 studies) Cardiac repolarization (Marjamaa A, 2012, 1 SNP) Cardiac repolarization (Sinner MF, 2012, 3 SNPs) Cardiac structure and function (Vasan RS, 2009, 4 SNPs) Cardiac Troponin-T levels (Yu B, 2012, 18 SNPs) Cardiovascular disease risk factors (16 SNPs from 3 studies) Cardiovascular disease risk factors (Middelberg RP, 2011, 19 SNPs) Cardiovascular disease risk factors (Schurks M, 2011, 5 SNPs) Cardiovascular disease risk factors (Smith EN, 2010, 6 SNPs) Cardiovascular heart disease in diabetics (Qi L, 2013, 1 SNP) Carotenoid and tocopherol levels (Ferrucci L, 2009, 2 SNPs) Carotid atherosclerosis in HIV infection (Shrestha S, 2010, 7 SNPs) Carotid intima media thickness (Bis JC, 2011, 11 SNPs) Carotid plaque burden (smoking interaction) (Della-Morte D, 2014, 4 SNPs) Cataracts in type 2 diabetes (Lin HJ, 2012, 2 SNPs) Caudate nucleus volume (Stein JL, 2011, 2 SNPs) CD4:CD8 lymphocyte ratio (Ferreira MA, 2009, 2 SNPs) Celiac disease (56 SNPs from 5 studies) Celiac disease (Dubois PC, 2010, 40 SNPs) Celiac disease (Garner C, 2014, 8 SNPs) Celiac disease (Hunt KA, 2008, 8 SNPs) Celiac disease (Ostensson M, 2013, 15 SNPs) Celiac disease (van Heel DA, 2007, 2 SNPs) Celiac disease or Rheumatoid arthritis (Zhernakova A, 2011, 15 SNPs) Central corneal thickness (5 SNPs from 4 studies) Central corneal thickness (Gao X, 2013, 2 SNPs) Central corneal thickness (Hoehn R, 2012, 2 SNPs) Central corneal thickness (Lu Y, 2010, 2 SNPs) Central corneal thickness (Vitart V, 2010, 5 SNPs) Cerebral amyloid angiopathy (Beecham GW, 2014, 6 SNPs) Cerebrospinal AB1-42 levels (Han MR, 2010, 7 SNPs) Cerebrospinal AB1-42 levels in Alzheimer's disease dementia (Ramirez A, 2014, 2 SNPs) Cerebrospinal fluid levels of Alzheimer's disease-related proteins (Kauwe JS, 2014, 5 SNPs) Cerebrospinal P-tau181p levels (Han MR, 2010, 5 SNPs) Cerebrospinal T-tau levels (Han MR, 2010, 5 SNPs) Cerivastatin-induced rhabdomyolysis (Marciante KD, 2011, 1 SNP) Cervical artery dissection (Debette S, 2014, 5 SNPs) Cervical cancer (13 SNPs from 3 studies) Cervical cancer (Chen D, 2013, 3 SNPs) Cervical cancer (Miura K, 2014, 9 SNPs) Cervical cancer (Shi Y, 2013, 4 SNPs) Chagas cardiomyopathy in Tripanosoma cruzi seropositivity (Deng X, 2013, 18 SNPs) Chemerin levels (Bozaoglu K, 2010, 7 SNPs) Cholelithiasis-related traits in sickle cell anemia (Milton JN, 2012, 1 SNP) Cholesterol (Igl W, 2010, 1 SNP) Cholesterol and Triglycerides (Surakka I, 2012, 1 SNP) Cholesterol, total (73 SNPs from 4 studies) Cholesterol, total (Aulchenko YS, 2008, 15 SNPs) Cholesterol, total (Ko A, 2014, 2 SNPs) Cholesterol, total (Teslovich TM, 2010, 52 SNPs) Cholesterol, total (Willer CJ, 2013, 73 SNPs) Chronic bronchitis and chronic obstructive pulmonary disease (Lee JH, 2014, 11 SNPs) Chronic bronchitis in chronic obstructive pulmonary disease (Lee JH, 2014, 1 SNP) Chronic hepatitis B infection (5 SNPs from 2 studies) Chronic hepatitis B infection (Chang SW, 2014, 9 SNPs) Chronic hepatitis B infection (Kim YJ, 2013, 6 SNPs) Chronic hepatitis C infection (5 SNPs from 5 studies) Chronic hepatitis C infection (Duggal P, 2013, 2 SNPs) Chronic hepatitis C infection (Fellay J, 2010, 2 SNPs) Chronic hepatitis C infection (Miki D, 2011, 1 SNP) Chronic hepatitis C infection (Miki D, 2013, 1 SNP) Chronic hepatitis C infection (Rauch A, 2010, 1 SNP) Chronic kidney disease (31 SNPs from 3 studies) Chronic kidney disease (Kottgen A, 2010, 28 SNPs) Chronic kidney disease (Nanayakkara S, 2013, 1 SNP) Chronic kidney disease (Pattaro C, 2012, 2 SNPs) Chronic kidney disease and serum creatinine levels (Gudbjartsson DF, 2010, 4 SNPs) Chronic lymphocytic leukemia (19 SNPs from 5 studies) Chronic lymphocytic leukemia (Berndt SI, 2013, 21 SNPs) Chronic lymphocytic leukemia (Di Bernardo MC, 2008, 6 SNPs) Chronic lymphocytic leukemia (Slager SL, 2010, 4 SNPs) Chronic lymphocytic leukemia (Slager SL, 2012, 8 SNPs) Chronic lymphocytic leukemia (Speedy HE, 2013, 19 SNPs) Chronic mucus hypersecretion (5 SNPs from 2 studies) Chronic mucus hypersecretion (Dijkstra AE, 2014, 1 SNP) Chronic mucus hypersecretion (Dijkstra AE, 2014, 4 SNPs) Chronic myeloid leukemia (Kim DH, 2011, 2 SNPs) Chronic obstructive pulmonary disease (5 SNPs from 5 studies) Chronic obstructive pulmonary disease (Cho MH, 2010, 3 SNPs) Chronic obstructive pulmonary disease (Cho MH, 2011, 4 SNPs) Chronic obstructive pulmonary disease (Lee JH, 2014, 3 SNPs) Chronic obstructive pulmonary disease (Lee JH, 2015, 5 SNPs) Chronic obstructive pulmonary disease (moderate to severe) (Cho MH, 2014, 9 SNPs) Chronic obstructive pulmonary disease (Pillai SG, 2009, 2 SNPs) Chronic obstructive pulmonary disease (severe) (Cho MH, 2014, 6 SNPs) Chronic obstructive pulmonary disease-related biomarkers (Kim DK, 2012, 34 SNPs) Chronic periodontitis (Feng P, 2014, 2 SNPs) Circulating cell-free DNA (Jylhava J, 2012, 1 SNP) Circulating myeloperoxidase levels (plasma) (Reiner AP, 2013, 3 SNPs) Circulating myeloperoxidase levels (serum) (Reiner AP, 2013, 5 SNPs) Circulating phylloquinone levels (Dashti HS, 2014, 5 SNPs) Circulating vasoactive peptide levels (Verweij N, 2013, 7 SNPs) Cleft lip (Beaty TH, 2010, 2 SNPs) Cleft plate (environmental tobacco smoke interaction) (Wu T, 2014, 1 SNP) Clozapine-induced agranulocytosis (Goldstein JI, 2014, 28 SNPs) Clubfoot (Zhang TX, 2014, 1 SNP) Coagulation factor levels (13 SNPs from 2 studies) Coagulation factor levels (Desch KC, 2012, 14 SNPs) Coagulation factor levels (Smith NL, 2010, 2 SNPs) Cocaine dependence (Gelernter J, 2013, 15 SNPs) Coffee consumption (6 SNPs from 3 studies) Coffee consumption (Amin N, 2011, 4 SNPs) Coffee consumption (Cornelis MC, 2014, 4 SNPs) Coffee consumption (cups per day) (Cornelis MC, 2014, 9 SNPs) Coffee consumption (Sulem P, 2011, 2 SNPs) Cognitive decline (1 SNP from 2 studies) Cognitive decline (age-related) (Zhang C, 2013, 11 SNPs) Cognitive decline (Davies G, 2012, 1 SNP) Cognitive decline (De Jager PL, 2011, 1 SNP) Cognitive function (27 SNPs from 2 studies) Cognitive function (Cox AJ, 2014, 25 SNPs) Cognitive function (LeBlanc M, 2011, 2 SNPs) Cognitive performance (119 SNPs from 2 studies) Cognitive performance (Cirulli ET, 2010, 62 SNPs) Cognitive performance (Need AC, 2009, 59 SNPs) Cognitive test performance (Seshadri S, 2007, 14 SNPs) Colorectal cancer (51 SNPs from 19 studies) Colorectal cancer (Broderick P, 2007, 1 SNP) Colorectal cancer (calcium intake interaction) (Du M, 2014, 3 SNPs) Colorectal cancer (Cui R, 2011, 2 SNPs) Colorectal cancer (diet interaction) (Figueiredo JC, 2014, 13 SNPs) Colorectal cancer (Dunlop MG, 2012, 3 SNPs) Colorectal cancer (Fernandez-Rozadilla C, 2013, 3 SNPs) Colorectal cancer (Houlston RS, 2008, 4 SNPs) Colorectal cancer (Houlston RS, 2010, 5 SNPs) Colorectal cancer (Jia WH, 2012, 7 SNPs) Colorectal cancer (Jiao S, 2012, 7 SNPs) Colorectal cancer (Peters U, 2011, 5 SNPs) Colorectal cancer (Peters U, 2012, 15 SNPs) Colorectal cancer (Schmit SL, 2014, 1 SNP) Colorectal cancer (Tenesa A, 2008, 3 SNPs) Colorectal cancer (Tomlinson I, 2007, 1 SNP) Colorectal cancer (Tomlinson IP, 2008, 5 SNPs) Colorectal cancer (Wang H, 2014, 1 SNP) Colorectal cancer (Whiffin N, 2014, 9 SNPs) Colorectal cancer (Zanke BW, 2007, 1 SNP) Colorectal cancer (Zhang B, 2014, 1 SNP) Colorectal cancer (Zhang B, 2014, 20 SNPs) Common traits (Other) (Eriksson N, 2010, 16 SNPs) Complement C3 and C4 levels (Yang X, 2012, 10 SNPs) Comprehensive strength and appendicular lean mass (Han Y, 2012, 2 SNPs) Conduct disorder (Dick DM, 2010, 12 SNPs) Conduct disorder (interaction) (Sonuga-Barke EJ, 2008, 15 SNPs) Conduct disorder (symptom count) (Dick DM, 2010, 17 SNPs) Congenital heart disease (Cordell HJ, 2013, 2 SNPs) Congenital heart malformation (Hu Z, 2013, 2 SNPs) Congenital left-sided heart lesions (maternal effect) (Mitchell LE, 2014, 1 SNP) Congenital left-sided heart lesions (Mitchell LE, 2014, 3 SNPs) Conotruncal heart defects (Agopian AJ, 2014, 11 SNPs) Contrast sensitivity (Goodbourn PT, 2013, 5 SNPs) Corneal astigmatism (30 SNPs from 3 studies) Corneal astigmatism (Fan Q, 2011, 6 SNPs) Corneal astigmatism (Lopes MC, 2013, 17 SNPs) Corneal astigmatism (Yazar S, 2013, 7 SNPs) Corneal curvature (14 SNPs from 4 studies) Corneal curvature (Chen P, 2014, 4 SNPs) Corneal curvature (Guggenheim JA, 2013, 1 SNP) Corneal curvature (Han S, 2011, 2 SNPs) Corneal curvature (Mishra A, 2012, 10 SNPs) Corneal structure (31 SNPs from 2 studies) Corneal structure (Li X, 2011, 5 SNPs) Corneal structure (Lu Y, 2013, 26 SNPs) Coronary arterial lesions in patients with Kawasaki disease (Kim JJ, 2013, 1 SNP) Coronary artery calcification (55 SNPs from 4 studies) Coronary artery calcification (O'Donnell CJ, 2007, 3 SNPs) Coronary artery calcification (O'Donnell CJ, 2011, 3 SNPs) Coronary artery calcification (van Setten J, 2013, 2 SNPs) Coronary artery calcification (Wojczynski MK, 2013, 48 SNPs) Coronary artery disease (23 SNPs from 2 studies) Coronary artery disease (Dichgans M, 2013, 23 SNPs) Coronary artery disease (Reilly MP, 2011, 3 SNPs) Coronary artery disease or ischemic stroke (Dichgans M, 2013, 15 SNPs) Coronary artery disease or large artery stroke (Dichgans M, 2013, 17 SNPs) Coronary heart disease (78 SNPs from 17 studies) Coronary heart disease (Davies RW, 2012, 5 SNPs) Coronary heart disease (Domarkiene I, 2013, 3 SNPs) Coronary heart disease (Erdmann J, 2009, 2 SNPs) Coronary heart disease (Erdmann J, 2010, 1 SNP) Coronary heart disease (Hager J, 2012, 3 SNPs) Coronary heart disease (Lee JY, 2013, 5 SNPs) Coronary heart disease (Lettre G, 2011, 3 SNPs) Coronary heart disease (Lu X, 2012, 8 SNPs) Coronary heart disease (Mehta NN, 2011, 2 SNPs) Coronary heart disease (Samani NJ, 2007, 7 SNPs) Coronary heart disease (Schunkert H, 2011, 30 SNPs) Coronary heart disease (Slavin TP, 2011, 10 SNPs) Coronary heart disease (Takeuchi F, 2011, 3 SNPs) Coronary heart disease (The Coronary Artery Disease (C4D) Genetics Consortium, 2011, 19 SNPs) Coronary heart disease (Tregouet DA, 2009, 8 SNPs) Coronary heart disease (Wild PS, 2011, 5 SNPs) Coronary heart disease (WTCCC, 2007, 4 SNPs) Coronary heart disease event reduction in response to statin therapy (interaction) (Shiffman D, 2012, 1 SNP) Coronary restenosis (Sampietro ML, 2011, 1 SNP) Coronary spasm (Suzuki S, 2007, 1 SNP) Cortical structure (interaction) (Bakken TE, 2012, 1 SNP) Cortical thickness (3 SNPs from 2 studies) Cortical thickness (Bakken TE, 2011, 1 SNP) Cortical thickness (Zheng HF, 2012, 2 SNPs) Cotinine glucuronidation (Patel Y, 2014, 14 SNPs) Creatine kinase in statin users (Dube MP, 2014, 2 SNPs) Creatinine levels (Chambers JC, 2010, 5 SNPs) Creutzfeldt-Jakob disease (Mead S, 2008, 2 SNPs) Creutzfeldt-Jakob disease (variant) (Sanchez-Juan P, 2011, 6 SNPs) Crohn's disease (85 SNPs from 15 studies) Crohn's disease (Barrett JC, 2008, 30 SNPs) Crohn's disease (Franke A, 2007, 3 SNPs) Crohn's disease (Franke A, 2010, 71 SNPs) Crohn's disease (Huang J, 2012, 1 SNP) Crohn's disease (Jostins L, 2012, 30 SNPs) Crohn's disease (Julia A, 2012, 10 SNPs) Crohn's disease (Kenny EE, 2012, 17 SNPs) Crohn's disease (Libioulle C, 2007, 3 SNPs) Crohn's disease (McGovern DP, 2010, 7 SNPs) Crohn's disease (need for surgery) (Dubinsky MC, 2013, 2 SNPs) Crohn's disease (Parkes M, 2007, 9 SNPs) Crohn's disease (Raelson JV, 2007, 33 SNPs) Crohn's disease (Rioux JD, 2007, 4 SNPs) Crohn's disease (time to surgery) (Dubinsky MC, 2013, 1 SNP) Crohn's disease (WTCCC, 2007, 13 SNPs) Crohn's disease (Yamazaki K, 2012, 11 SNPs) Crohn's disease (Yang SK, 2013, 8 SNPs) Crohn's disease and celiac disease (Festen EA, 2011, 2 SNPs) Crohn's disease and psoriasis (Ellinghaus D, 2012, 4 SNPs) Crohn's disease and sarcoidosis (combined) (Franke A, 2008, 1 SNP) Crohn's disease-related phenotypes (Alonso A, 2014, 7 SNPs) Current cigarettes per day in chronic obstructive pulmonary disease (Siedlinski M, 2011, 7 SNPs) Cutaneous nevi (4 SNPs from 2 studies) Cutaneous nevi (Falchi M, 2009, 2 SNPs) Cutaneous nevi (Nan H, 2011, 3 SNPs) Cystatin C (Hwang SJ, 2007, 1 SNP) Cystic fibrosis severity (Wright FA, 2011, 6 SNPs) Cystic fibrosis-related diabetes (Blackman SM, 2013, 1 SNP) Cytomegalovirus antibody response (Kuparinen T, 2011, 9 SNPs) D-dimer levels (Smith NL, 2011, 15 SNPs) Dehydroepiandrosterone sulphate levels (Zhai G, 2011, 8 SNPs) Dementia and core Alzheimer's disease neuropathologic changes (Beecham GW, 2014, 27 SNPs) Dengue shock syndrome (Khor CC, 2011, 4 SNPs) Dental caries (45 SNPs from 3 studies) Dental caries (Shaffer JR, 2011, 3 SNPs) Dental caries (Shaffer JR, 2012, 32 SNPs) Dental caries (Wang X, 2012, 34 SNPs) Depression (quantitative trait) (13 SNPs from 2 studies) Depression (quantitative trait) (Hek K, 2013, 2 SNPs) Depression (quantitative trait) (Terracciano A, 2010, 11 SNPs) Depression and alcohol dependence (Edwards AC, 2011, 8 SNPs) Dermatomyositis (Miller FW, 2013, 1 SNP) Diabetes (gestational) (Kwak SH, 2012, 3 SNPs) Diabetes (incident) (Meigs JB, 2007, 1 SNP) Diabetes related insulin traits (Meigs JB, 2007, 4 SNPs) Diabetic nephropathy in type 1 diabetes (Germain M, 2014, 1 SNP) Diabetic retinopathy (28 SNPs from 3 studies) Diabetic retinopathy (Grassi MA, 2011, 19 SNPs) Diabetic retinopathy (Huang YC, 2011, 8 SNPs) Diabetic retinopathy (Sheu WH, 2013, 1 SNP) Diabetic retinopathy in type 2 diabetes (Awata T, 2014, 1 SNP) Dialysis-related mortality (Murea M, 2011, 26 SNPs) Diastolic blood pressure (28 SNPs from 4 studies) Diastolic blood pressure (alcohol consumption interaction) (Simino J, 2013, 4 SNPs) Diastolic blood pressure (Ehret GB, 2011, 19 SNPs) Diastolic blood pressure (Levy D, 2009, 7 SNPs) Diastolic blood pressure (Lu X, 2014, 14 SNPs) Diastolic blood pressure (Newton-Cheh C, 2009, 6 SNPs) Dietary macronutrient intake (7 SNPs from 2 studies) Dietary macronutrient intake (Chu AY, 2013, 3 SNPs) Dietary macronutrient intake (Tanaka T, 2013, 7 SNPs) Diffuse large B cell lymphoma (Cerhan JR, 2014, 8 SNPs) Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined) (Levine DM, 2013, 10 SNPs) Digit length ratio (2 SNPs from 2 studies) Digit length ratio (Lawrance-Owen AJ, 2012, 1 SNP) Digit length ratio (Medland SE, 2010, 1 SNP) Dilated cardiomyopathy (Villard E, 2011, 2 SNPs) Disc degeneration (lumbar) (37 SNPs from 2 studies) Disc degeneration (lumbar) (Song YQ, 2013, 2 SNPs) Disc degeneration (lumbar) (Williams FM, 2012, 35 SNPs) DNA methylation (parent-of-origin) (Renteria ME, 2013, 7 SNPs) DNA methylation (variation) (Renteria ME, 2013, 19 SNPs) Drinking behavior (2 SNPs from 2 studies) Drinking behavior (Takeuchi F, 2011, 2 SNPs) Drinking behavior (Yang X, 2013, 1 SNP) Drug-induced liver injury (amoxicillin-clavulanate) (Lucena MI, 2011, 2 SNPs) Drug-induced liver injury (flucloxacillin) (Daly AK, 2009, 6 SNPs) Drug-induced liver injury (Urban TJ, 2012, 1 SNP) Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN) (10 SNPs from 2 studies) Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN) (Genin E, 2011, 6 SNPs) Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN) (Shen Y, 2011, 4 SNPs) Drug-induced torsades de pointes (Behr ER, 2013, 1 SNP) Duodenal ulcer (Tanikawa C, 2012, 2 SNPs) Dupuytren's disease (13 SNPs from 2 studies) Dupuytren's disease (Dolmans GH, 2011, 12 SNPs) Dupuytren's disease (Ojwang JO, 2010, 1 SNP) E-selectin levels (Qi L, 2010, 1 SNP) Eating disorders (15 SNPs from 2 studies) Eating disorders (Boraska V, 2012, 7 SNPs) Eating disorders (purging via substances) (Wade TD, 2013, 11 SNPs) Eating disorders (Wade TD, 2013, 8 SNPs) Echocardiographic traits (Vasan RS, 2007, 8 SNPs) Economic and political preferences (Benjamin DJ, 2012, 17 SNPs) Economic and political preferences (environmentalism) (Benjamin DJ, 2012, 17 SNPs) Economic and political preferences (fairness) (Benjamin DJ, 2012, 7 SNPs) Economic and political preferences (feminism/equality) (Benjamin DJ, 2012, 12 SNPs) Economic and political preferences (immigration/crime) (Benjamin DJ, 2012, 15 SNPs) Economic and political preferences (time) (Benjamin DJ, 2012, 10 SNPs) Educational attainment (60 SNPs from 2 studies) Educational attainment (Rietveld CA, 2013, 13 SNPs) Educational attainment (Rietveld CA, 2014, 68 SNPs) Ejection fraction in Tripanosoma cruzi seropositivity (Deng X, 2013, 25 SNPs) Electrocardiographic conduction measures (10 SNPs from 2 studies) Electrocardiographic conduction measures (Ritchie MD, 2013, 5 SNPs) Electrocardiographic conduction measures (Smith JG, 2009, 7 SNPs) Electrocardiographic traits (22 SNPs from 4 studies) Electrocardiographic traits (Chambers JC, 2010, 3 SNPs) Electrocardiographic traits (Holm H, 2010, 18 SNPs) Electrocardiographic traits (Newton-Cheh C, 2007, 2 SNPs) Electrocardiographic traits (Sano M, 2014, 9 SNPs) Electrodermal activity (Vaidyanathan U, 2014, 13 SNPs) Electroencephalogram traits (Malone SM, 2014, 27 SNPs) Electroencephalographic traits in alcoholism (Kang SJ, 2012, 8 SNPs) Elevated serum carcinoembryonic antigen levels (Liang Y, 2014, 13 SNPs) Emphysema-related traits (Kong X, 2010, 7 SNPs) End-stage coagulation (Williams FM, 2013, 23 SNPs) End-stage renal disease (Hanson RL, 2007, 1 SNP) End-stage renal disease (non-diabetic) (Bostrom MA, 2010, 1 SNP) End-stage renal disease in Type 1 diabetics (Sandholm N, 2013, 1 SNP) Endometrial cancer (11 SNPs from 2 studies) Endometrial cancer (De Vivo I, 2013, 9 SNPs) Endometrial cancer (Spurdle AB, 2011, 2 SNPs) Endometriosis (5 SNPs from 5 studies) Endometriosis (Adachi S, 2010, 2 SNPs) Endometriosis (Albertsen HM, 2013, 23 SNPs) Endometriosis (Nyholt DR, 2012, 7 SNPs) Endometriosis (Painter JN, 2010, 3 SNPs) Endometriosis (Uno S, 2010, 2 SNPs) Endothelial function traits (Vasan RS, 2007, 1 SNP) Endothelial growth factor levels (Lieb W, 2014, 3 SNPs) Enteric fever (Dunstan SJ, 2014, 1 SNP) Entorhinal cortical thickness (Furney SJ, 2010, 6 SNPs) Eosinophil counts (Gudbjartsson DF, 2009, 7 SNPs) Eosinophilic esophagitis (19 SNPs from 2 studies) Eosinophilic esophagitis (Kottyan LC, 2014, 17 SNPs) Eosinophilic esophagitis (pediatric) (Rothenberg ME, 2010, 14 SNPs) Eosinophilic esophagitis (Sleiman PM, 2014, 6 SNPs) Epilepsy (10 SNPs from 2 studies) Epilepsy (Anney RJ, 2014, 9 SNPs) Epilepsy (generalized) (EPICURE Consortium, 2012, 10 SNPs) Epilepsy (Guo Y, 2011, 1 SNP) Epilepsy (remission after treatment) (Speed D, 2013, 7 SNPs) Epirubicin-induced leukopenia (Srinivasan Y, 2011, 2 SNPs) Episodic memory (Ramanan VK, 2014, 1 SNP) Epithelial ovarian cancer (Chen K, 2014, 6 SNPs) Epstein-Barr virus immune response (EBNA-1) (Rubicz R, 2013, 2 SNPs) Erectile dysfunction and prostate cancer treatment (Kerns SL, 2010, 23 SNPs) Erectile dysfunction in type 1 diabetes (Hotaling JM, 2012, 6 SNPs) Erythema nodosum in inflammatory bowel disease (Weizman A, 2014, 5 SNPs) Erythrocyte sedimentation rate (Kullo IJ, 2011, 5 SNPs) Esophageal adenocarcinoma (Levine DM, 2013, 8 SNPs) Esophageal cancer (alcohol interaction) (Wu C, 2012, 4 SNPs) Esophageal cancer (10 SNPs from 2 studies) Esophageal cancer (Cui R, 2009, 2 SNPs) Esophageal cancer (squamous cell) (Wu C, 2012, 7 SNPs) Esophageal cancer (Wu C, 2011, 11 SNPs) Esophageal cancer and gastric cancer (Abnet CC, 2010, 4 SNPs) Esophageal squamous cell cancer (length of survival) (Wu C, 2013, 1 SNP) Esophageal squamous cell carcinoma (Wu C, 2014, 10 SNPs) Essential tremor (2 SNPs from 2 studies) Essential tremor (Stefansson H, 2009, 1 SNP) Essential tremor (Thier S, 2012, 1 SNP) Estradiol levels (Prescott J, 2012, 8 SNPs) Estradiol plasma levels (breast cancer) (Liu M, 2013, 18 SNPs) Event-related brain oscillations (Zlojutro M, 2010, 3 SNPs) Ewing sarcoma (Postel-Vinay S, 2012, 3 SNPs) Exercise (leisure time) (De Moor MH, 2009, 3 SNPs) Exercise treadmill test traits (Vasan RS, 2007, 4 SNPs) Exfoliation glaucoma or exfoliation syndrome (Nakano M, 2014, 2 SNPs) Exhaled carbon monoxide levels (Bloom AJ, 2014, 1 SNP) Expressive vocabulary in infants (St Pourcain B, 2014, 8 SNPs) Eye color (12 SNPs from 3 studies) Eye color (Candille SI, 2012, 3 SNPs) Eye color (Eriksson N, 2010, 8 SNPs) Eye color (Zhang M, 2013, 8 SNPs) Eye color traits (Liu F, 2010, 3 SNPs) F-cell distribution (11 SNPs from 2 studies) F-cell distribution (Bhatnagar P, 2011, 49 SNPs) F-cell distribution (Menzel S, 2007, 2 SNPs) Facial morphology (Paternoster L, 2012, 1 SNP) Factor VII (Yang Q, 2007, 4 SNPs) Fasting glucose-related traits (Dupuis J, 2010, 30 SNPs) Fasting glucose-related traits (interaction with BMI) (Manning AK, 2012, 31 SNPs) Fasting insulin (interaction) (Zheng JS, 2013, 14 SNPs) Fasting insulin-related traits (Dupuis J, 2010, 4 SNPs) Fasting insulin-related traits (interaction with BMI) (Manning AK, 2012, 20 SNPs) Fasting plasma glucose (21 SNPs from 9 studies) Fasting plasma glucose (Bouatia-Naji N, 2008, 1 SNP) Fasting plasma glucose (Bouatia-Naji N, 2008, 1 SNP) Fasting plasma glucose (Chambers JC, 2009, 1 SNP) Fasting plasma glucose (Chen WM, 2008, 1 SNP) Fasting plasma glucose (childhood) (Go MJ, 2014, 1 SNP) Fasting plasma glucose (Hwang JY, 2014, 15 SNPs) Fasting plasma glucose (Meigs JB, 2007, 6 SNPs) Fasting plasma glucose (Prokopenko I, 2008, 3 SNPs) Fasting plasma glucose (Rasmussen-Torvik LJ, 2012, 3 SNPs) Fasting plasma glucose (Xing C, 2010, 1 SNP) Fat body mass (Pei YF, 2013, 2 SNPs) Fat distribution (HIV) (Irvin MR, 2011, 17 SNPs) Febrile seizures (Feenstra B, 2014, 7 SNPs) Febrile seizures (MMR vaccine-related) (Feenstra B, 2014, 10 SNPs) Febrile seizures (MMR vaccine-unrelated) (Feenstra B, 2014, 4 SNPs) Femoral neck bone geometry (Sun L, 2011, 2 SNPs) Femoral neck bone geometry and menarche (age at onset) (Ran S, 2013, 6 SNPs) Fetal hemoglobin levels (2 SNPs from 2 studies) Fetal hemoglobin levels (Solovieff N, 2009, 3 SNPs) Fetal hemoglobin levels (Uda M, 2008, 2 SNPs) Fetal hemoglobin levels in sickle cell anemia (Mtatiro SN, 2014, 2 SNPs) Fibrinogen (24 SNPs from 4 studies) Fibrinogen (Danik JS, 2009, 6 SNPs) Fibrinogen (Dehghan A, 2009, 4 SNPs) Fibrinogen (Lovely RS, 2011, 5 SNPs) Fibrinogen (Sabater-Lleal M, 2013, 24 SNPs) Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction) (Baumert J, 2014, 3 SNPs) Folate pathway vitamin levels (9 SNPs from 2 studies) Folate pathway vitamin levels (Hazra A, 2009, 9 SNPs) Folate pathway vitamin levels (Tanaka T, 2009, 5 SNPs) Follicular lymphoma (11 SNPs from 4 studies) Follicular lymphoma (Conde L, 2010, 3 SNPs) Follicular lymphoma (Skibola CF, 2009, 1 SNP) Follicular lymphoma (Skibola CF, 2014, 9 SNPs) Follicular lymphoma (Smedby KE, 2011, 1 SNP) Follicule stimulating hormone (Chen Z, 2013, 6 SNPs) Food antigen IgG levels (Rubicz R, 2014, 7 SNPs) Forced expiratory volume in 1 second (Liao SY, 2014, 2 SNPs) Forced vital capacity (Loth DW, 2014, 7 SNPs) Formal thought disorder in schizophrenia (Wang KS, 2012, 5 SNPs) Fractional exhaled nitric oxide (childhood) (van der Valk RJ, 2013, 25 SNPs) Fractional exhaled nitric oxide levels (Bouzigon E, 2014, 2 SNPs) Freckles (5 SNPs from 2 studies) Freckles (Sulem P, 2007, 3 SNPs) Freckles (Sulem P, 2008, 2 SNPs) Freckling (Eriksson N, 2010, 4 SNPs) Free thyroxine concentration (Kwak SH, 2014, 3 SNPs) Frontotemporal dementia (3 SNPs from 2 studies) Frontotemporal dementia (Diekstra FP, 2014, 1 SNP) Frontotemporal dementia (Ferrari R, 2014, 2 SNPs) Fuchs's corneal dystrophy (Baratz KH, 2010, 2 SNPs) Functional impairment in major depressive disorder, bipolar disorder and schizophrenia (McGrath LM, 2013, 5 SNPs) Functional MRI (Liu X, 2010, 2 SNPs) Gallbladder cancer (Cha PC, 2012, 5 SNPs) Gallstones (Buch S, 2007, 1 SNP) Gambling (Lind PA, 2012, 5 SNPs) Gamma gluatamyl transferase levels (Middelberg RP, 2011, 4 SNPs) Gamma glutamyl transpeptidase (Kim YJ, 2011, 7 SNPs) Gastric cancer (Shi Y, 2011, 2 SNPs) Gastritis (Oh S, 2014, 7 SNPs) Gaucher disease severity (Zhang CK, 2012, 3 SNPs) General cognitive ability (Kirkpatrick RM, 2014, 3 SNPs) Glaucoma (12 SNPs from 4 studies) Glaucoma (Burdon KP, 2011, 2 SNPs) Glaucoma (exfoliation) (Thorleifsson G, 2007, 1 SNP) Glaucoma (high intraocular pressure) (Chen Y, 2014, 2 SNPs) Glaucoma (Hoffmann TJ, 2014, 8 SNPs) Glaucoma (Meguro A, 2010, 2 SNPs) Glaucoma (primary angle closure) (Vithana EN, 2012, 5 SNPs) Glaucoma (primary open-angle) (11 SNPs from 5 studies) Glaucoma (primary open-angle) (Gharahkhani P, 2014, 9 SNPs) Glaucoma (primary open-angle) (Nakano M, 2012, 1 SNP) Glaucoma (primary open-angle) (Osman W, 2012, 3 SNPs) Glaucoma (primary open-angle) (Thorleifsson G, 2010, 1 SNP) Glaucoma (primary open-angle) (Wiggs JL, 2012, 4 SNPs) Glaucoma (Takamoto M, 2012, 1 SNP) Glioblastoma (Xiao Y, 2012, 1 SNP) Glioma (7 SNPs from 4 studies) Glioma (high-grade) (4 SNPs from 2 studies) Glioma (high-grade) (Walsh KM, 2014, 3 SNPs) Glioma (high-grade) (Wrensch M, 2009, 3 SNPs) Glioma (Rajaraman P, 2012, 3 SNPs) Glioma (Sanson M, 2011, 7 SNPs) Glioma (Shete S, 2009, 7 SNPs) Glioma (Yang TH, 2011, 1 SNP) Glomerular filtration rate (10 SNPs from 2 studies) Glomerular filtration rate (Nanayakkara S, 2013, 4 SNPs) Glomerular filtration rate (Tin A, 2013, 6 SNPs) Glomerulosclerosis (Genovese G, 2010, 1 SNP) Glucose homeostasis traits (Palmer ND, 2014, 74 SNPs) Glycated hemoglobin levels (20 SNPs from 7 studies) Glycated hemoglobin levels (An P, 2013, 1 SNP) Glycated hemoglobin levels (Chen P, 2013, 3 SNPs) Glycated hemoglobin levels (Chen P, 2014, 12 SNPs) Glycated hemoglobin levels (Franklin CS, 2010, 1 SNP) Glycated hemoglobin levels (Pare G, 2008, 4 SNPs) Glycated hemoglobin levels (Ryu J, 2012, 1 SNP) Glycated hemoglobin levels (Soranzo N, 2010, 11 SNPs) Glycemic traits (Go MJ, 2013, 11 SNPs) Glycemic traits (pregnancy) (Hayes MG, 2013, 10 SNPs) Gout (6 SNPs from 2 studies) Gout (Kottgen A, 2012, 6 SNPs) Gout (Sulem P, 2011, 2 SNPs) Graves' disease (18 SNPs from 3 studies) Graves' disease (Chu X, 2011, 11 SNPs) Graves' disease (Nakabayashi K, 2011, 7 SNPs) Graves' disease (Zhao SX, 2013, 6 SNPs) Gray matter volume (schizophrenia interaction) (Wang Q, 2013, 3 SNPs) Hair color (14 SNPs from 3 studies) Hair color (Eriksson N, 2010, 12 SNPs) Hair color (Kenny EE, 2012, 1 SNP) Hair color (Zhang M, 2013, 6 SNPs) Hair morphology (Medland SE, 2009, 15 SNPs) Handedness (Armour JA, 2013, 2 SNPs) Handedness in dyslexia (Scerri TS, 2010, 1 SNP) Haptoglobin levels (Froguel P, 2012, 1 SNP) Hashimoto thyroiditis versus Graves' disease (Oryoji D, 2014, 3 SNPs) HbA2 levels (Menzel S, 2012, 2 SNPs) HDL cholesterol (86 SNPs from 16 studies) HDL cholesterol (Aulchenko YS, 2008, 10 SNPs) HDL cholesterol (Coram MA, 2013, 8 SNPs) HDL cholesterol (Heid IM, 2008, 3 SNPs) HDL cholesterol (Hiura Y, 2009, 1 SNP) HDL cholesterol (Kathiresan S, 2008, 14 SNPs) HDL cholesterol (Kathiresan S, 2008, 6 SNPs) HDL cholesterol (Kim YJ, 2011, 9 SNPs) HDL cholesterol (Ko A, 2014, 2 SNPs) HDL cholesterol (Lettre G, 2011, 18 SNPs) HDL cholesterol (Ridker PM, 2009, 1 SNP) HDL cholesterol (Sabatti C, 2008, 5 SNPs) HDL cholesterol (Teslovich TM, 2010, 47 SNPs) HDL cholesterol (Waterworth DM, 2010, 12 SNPs) HDL cholesterol (Weissglas-Volkov D, 2013, 5 SNPs) HDL cholesterol (Willer CJ, 2008, 10 SNPs) HDL cholesterol (Willer CJ, 2013, 71 SNPs) HDL Cholesterol - Triglycerides (HDLC-TG) (Kraja AT, 2011, 8 SNPs) HDL Cholesterol in HIV-infection (Moore CB, 2015, 1 SNP) Head circumference (infant) (Taal HR, 2012, 3 SNPs) Hearing function (Wolber LE, 2014, 5 SNPs) Hearing impairment (Van Laer L, 2010, 2 SNPs) Heart failure (17 SNPs from 2 studies) Heart failure (Larson MG, 2007, 1 SNP) Heart failure (Smith NL, 2010, 16 SNPs) Heart rate (37 SNPs from 2 studies) Heart rate (den Hoed M, 2013, 32 SNPs) Heart rate (Jeff JM, 2013, 5 SNPs) Heart rate variability traits (4 SNPs from 2 studies) Heart rate variability traits (Newton-Cheh C, 2007, 2 SNPs) Heart rate variability traits (Rankinen T, 2011, 2 SNPs) Height (255 SNPs from 24 studies) Height (Berndt SI, 2013, 86 SNPs) Height (Carty CL, 2011, 8 SNPs) Height (Cho YS, 2009, 5 SNPs) Height (Croteau-Chonka DC, 2010, 7 SNPs) Height (Estrada K, 2009, 5 SNPs) Height (Gudbjartsson DF, 2008, 52 SNPs) Height (Hao Y, 2013, 11 SNPs) Height (He M, 2014, 125 SNPs) Height (Johansson A, 2008, 1 SNP) Height (Kim HN, 2010, 1 SNP) Height (Kim JJ, 2009, 15 SNPs) Height (Lango Allen H, 2010, 199 SNPs) Height (Lei SF, 2008, 1 SNP) Height (Lettre G, 2008, 18 SNPs) Height (Liu JZ, 2010, 8 SNPs) Height (N'Diaye A, 2011, 33 SNPs) Height (Okada Y, 2010, 25 SNPs) Height (Sanna S, 2008, 5 SNPs) Height (Scannell Bryan M, 2014, 3 SNPs) Height (Soranzo N, 2009, 20 SNPs) Height (Tonjes A, 2009, 1 SNP) Height (Weedon MN, 2007, 1 SNP) Height (Weedon MN, 2008, 20 SNPs) Height (Wood AR, 2014, 170 SNPs) Height adjusted BMI (Stergiakouli E, 2014, 2 SNPs) Helicobacter pylori serologic status (Mayerle J, 2013, 2 SNPs) Hematocrit (Ganesh SK, 2009, 8 SNPs) Hematological and biochemical traits (Kamatani Y, 2010, 29 SNPs) Hematological parameters (Soranzo N, 2009, 12 SNPs) Hematology traits (20 SNPs from 3 studies) Hematology traits (Ferreira MA, 2009, 6 SNPs) Hematology traits (Hong KW, 2013, 5 SNPs) Hematology traits (Li J, 2012, 12 SNPs) Hemoglobin (7 SNPs from 2 studies) Hemoglobin (Chambers JC, 2009, 2 SNPs) Hemoglobin (Ganesh SK, 2009, 7 SNPs) Hemoglobin A2 levels in sickle cell anemia (Griffin PJ, 2014, 3 SNPs) Hemostatic factors and hematological phenotypes (30 SNPs from 2 studies) Hemostatic factors and hematological phenotypes (Oudot-Mellakh T, 2012, 12 SNPs) Hemostatic factors and hematological phenotypes (Yang Q, 2007, 18 SNPs) Hepatic lipid content in extreme obesity (DiStefano JK, 2014, 4 SNPs) Hepatitis (Hong Y, 2014, 9 SNPs) Hepatitis B (2 SNPs from 4 studies) Hepatitis B (Hu Z, 2013, 3 SNPs) Hepatitis B (Kamatani Y, 2009, 1 SNP) Hepatitis B (Liu L, 2011, 1 SNP) Hepatitis B (Mbarek H, 2011, 4 SNPs) Hepatitis B (viral clearance) (Nishida N, 2012, 4 SNPs) Hepatitis B vaccine response (1 SNP from 2 studies) Hepatitis B vaccine response (Pan L, 2013, 2 SNPs) Hepatitis B vaccine response (Png E, 2011, 3 SNPs) Hepatitis C induced liver cirrhosis (Urabe Y, 2013, 5 SNPs) Hepatitis C induced liver fibrosis (Patin E, 2012, 6 SNPs) Hepatocellular carcinoma (6 SNPs from 4 studies) Hepatocellular carcinoma (Clifford RJ, 2010, 3 SNPs) Hepatocellular carcinoma (hepatitis B virus related) (Jiang DK, 2012, 2 SNPs) Hepatocellular carcinoma (Kumar V, 2011, 2 SNPs) Hepatocellular carcinoma (Li S, 2012, 3 SNPs) Hepatocellular carcinoma (Zhang H, 2010, 1 SNP) Hepcidin levels (Traglia M, 2011, 8 SNPs) Hereditary hemochromatosis-related traits (HFE mutation homozygotes) (de Tayrac M, 2014, 2 SNPs) Heschl's gyrus morphology (Cai DC, 2014, 33 SNPs) High serum lipase activity (Weiss FU, 2014, 1 SNP) Hip bone size (Liu YZ, 2008, 1 SNP) Hip circumference (psychosocial stress interaction) (Singh A, 2014, 5 SNPs) Hip geometry (Kiel DP, 2007, 16 SNPs) Hippocampal atrophy (33 SNPs from 3 studies) Hippocampal atrophy (Mather KA, 2015, 3 SNPs) Hippocampal atrophy (Melville SA, 2012, 10 SNPs) Hippocampal atrophy (Potkin SG, 2009, 21 SNPs) Hippocampal sclerosis (Beecham GW, 2014, 13 SNPs) Hippocampal sclerosis of aging (Nelson PT, 2014, 1 SNP) Hippocampal volume (24 SNPs from 2 studies) Hippocampal volume (Bis JC, 2012, 5 SNPs) Hippocampal volume (Mather KA, 2015, 19 SNPs) Hirschsprung disease (6 SNPs from 2 studies) Hirschsprung disease (Garcia-Barcelo MM, 2009, 2 SNPs) Hirschsprung disease (Kim JH, 2014, 6 SNPs) HIV-1 control (32 SNPs from 2 studies) HIV-1 control (Fellay J, 2009, 42 SNPs) HIV-1 control (Pereyra F, 2010, 8 SNPs) HIV-1 progression (Herbeck JT, 2010, 1 SNP) HIV-1 replication (Bol SM, 2011, 1 SNP) HIV-1 susceptibility (16 SNPs from 3 studies) HIV-1 susceptibility (Lingappa JR, 2011, 9 SNPs) HIV-1 susceptibility (McLaren PJ, 2013, 1 SNP) HIV-1 susceptibility (Petrovski S, 2010, 6 SNPs) HIV-1 viral setpoint (24 SNPs from 2 studies) HIV-1 viral setpoint (Lingappa JR, 2011, 14 SNPs) HIV-1 viral setpoint (Pelak K, 2010, 10 SNPs) HIV-associated dementia (Levine AJ, 2012, 4 SNPs) Hoarding (Perroud N, 2010, 3 SNPs) Hodgkin's lymphoma (10 SNPs from 4 studies) Hodgkin's lymphoma (Cozen W, 2014, 7 SNPs) Hodgkin's lymphoma (Enciso-Mora V, 2010, 5 SNPs) Hodgkin's lymphoma (Frampton M, 2013, 6 SNPs) Hodgkin's lymphoma (Urayama KY, 2012, 4 SNPs) Homeostasis model assessment of beta-cell function (interaction) (Zheng JS, 2013, 12 SNPs) Homeostasis model assessment of insulin resistance (interaction) (Zheng JS, 2013, 15 SNPs) Homoarginine levels (Kleber ME, 2013, 1 SNP) Homocysteine levels (17 SNPs from 3 studies) Homocysteine levels (Lange LA, 2010, 1 SNP) Homocysteine levels (Pare G, 2009, 2 SNPs) Homocysteine levels (van Meurs JB, 2013, 18 SNPs) Hormone measurements (Chen Z, 2013, 7 SNPs) HPV seropositivity (Chen D, 2011, 1 SNP) Hyperactive-impulsive symptoms (Lasky-Su J, 2008, 14 SNPs) Hyperopia (Simpson CL, 2014, 5 SNPs) Hypersomnia (HLA-DQB1*06:02 negative) (Khor SS, 2013, 5 SNPs) Hypertension (57 SNPs from 10 studies) Hypertension (Adeyemo A, 2009, 2 SNPs) Hypertension (Ehret GB, 2011, 11 SNPs) Hypertension (Guo Y, 2012, 3 SNPs) Hypertension (Lettre G, 2011, 8 SNPs) Hypertension (Levy D, 2009, 4 SNPs) Hypertension (Lu X, 2014, 12 SNPs) Hypertension (Org E, 2009, 1 SNP) Hypertension (Padmanabhan S, 2010, 1 SNP) Hypertension (Slavin TP, 2011, 18 SNPs) Hypertension (WTCCC, 2007, 2 SNPs) Hypertension (young onset) (Yang HC, 2009, 4 SNPs) Hypertension risk in short sleep duration (Kim SJ, 2012, 3 SNPs) Hypertriglyceridemia (9 SNPs from 2 studies) Hypertriglyceridemia (Johansen CT, 2010, 5 SNPs) Hypertriglyceridemia (Weissglas-Volkov D, 2013, 9 SNPs) Hypospadias (24 SNPs from 2 studies) Hypospadias (Geller F, 2014, 24 SNPs) Hypospadias (van der Zanden LF, 2010, 1 SNP) Hypothyroidism (19 SNPs from 2 studies) Hypothyroidism (Denny JC, 2011, 1 SNP) Hypothyroidism (Eriksson N, 2012, 19 SNPs) Idiopathic membranous nephropathy (Stanescu HC, 2011, 21 SNPs) Idiopathic pulmonary fibrosis (6 SNPs from 2 studies) Idiopathic pulmonary fibrosis (Mushiroda T, 2008, 1 SNP) Idiopathic pulmonary fibrosis (Noth I, 2013, 5 SNPs) IFN-related cytopenia (Thompson AJ, 2011, 1 SNP) IgA levels (Yang C, 2012, 1 SNP) IgA nephropathy (21 SNPs from 2 studies) IgA nephropathy (Kiryluk K, 2014, 32 SNPs) IgA nephropathy (Yu XQ, 2011, 9 SNPs) IgE grass sensitization (Ramasamy A, 2011, 9 SNPs) IgE levels (12 SNPs from 4 studies) IgE levels (Granada M, 2011, 11 SNPs) IgE levels (Levin AM, 2012, 4 SNPs) IgE levels (Weidinger S, 2008, 2 SNPs) IgE levels (Yatagai Y, 2013, 1 SNP) IgE levels in asthmatics (D.f. specific) (Kim JH, 2013, 2 SNPs) IgE levels in asthmatics (D.p. specific) (Kim JH, 2013, 3 SNPs) IgE levels in asthmatics (Kim JH, 2013, 4 SNPs) IgG glycosylation (Lauc G, 2013, 699 SNPs) IgG levels (2 SNPs from 2 studies) IgG levels (Buck D, 2012, 1 SNP) IgG levels (Liao M, 2012, 1 SNP) IgM levels (Yang M, 2012, 3 SNPs) Ileal carcinoids (Walsh KM, 2010, 4 SNPs) Illicit drug use (McGue M, 2013, 10 SNPs) Immune reponse to smallpox (secreted IFN-alpha) (Kennedy RB, 2012, 32 SNPs) Immune reponse to smallpox (secreted IL-10) (Kennedy RB, 2012, 6 SNPs) Immune reponse to smallpox (secreted IL-12p40) (Kennedy RB, 2012, 10 SNPs) Immune reponse to smallpox (secreted IL-1beta) (Kennedy RB, 2012, 13 SNPs) Immune reponse to smallpox (secreted IL-2) (Kennedy RB, 2012, 17 SNPs) Immune reponse to smallpox (secreted TNF-alpha) (Kennedy RB, 2012, 6 SNPs) Immune response to anthrax vaccine (Pajewski NM, 2012, 8 SNPs) Immune response to measles-mumps-rubella vaccine (Kennedy RB, 2014, 10 SNPs) Immune response to smallpox vaccine (IL-6) (46 SNPs from 2 studies) Immune response to smallpox vaccine (IL-6) (Kennedy RB, 2012, 9 SNPs) Immune response to smallpox vaccine (IL-6) (Ovsyannikova IG, 2012, 37 SNPs) Immunoglobulin A (Ferreira RC, 2010, 12 SNPs) Inattentive symptoms (Lasky-Su J, 2008, 15 SNPs) Infant length (van der Valk RJ, 2014, 15 SNPs) Infantile hypertrophic pyloric stenosis (5 SNPs from 2 studies) Infantile hypertrophic pyloric stenosis (Feenstra B, 2012, 5 SNPs) Infantile hypertrophic pyloric stenosis (Feenstra B, 2013, 4 SNPs) Inflammatory biomarkers (29 SNPs from 3 studies) Inflammatory biomarkers (Aslibekyan S, 2012, 19 SNPs) Inflammatory biomarkers (Matteini AM, 2013, 3 SNPs) Inflammatory biomarkers (Naitza S, 2012, 7 SNPs) Inflammatory biomarkers in Kawasaki disease (Kim JJ, 2014, 1 SNP) Inflammatory bowel disease (110 SNPs from 3 studies) Inflammatory bowel disease (Duerr RH, 2006, 1 SNP) Inflammatory bowel disease (early onset) (Imielinski M, 2009, 4 SNPs) Inflammatory bowel disease (Jostins L, 2012, 110 SNPs) Inflammatory bowel disease (Kugathasan S, 2008, 6 SNPs) Information processing speed (Luciano M, 2010, 25 SNPs) Insomnia (Byrne EM, 2013, 3 SNPs) Insomnia (caffeine-induced) (Byrne EM, 2012, 9 SNPs) Insulin resistance/response (Irvin MR, 2011, 14 SNPs) Insulin-like growth factors (Kaplan RC, 2011, 8 SNPs) Insulin-related traits (Chen G, 2012, 6 SNPs) Intelligence (childhood) (Benyamin B, 2013, 6 SNPs) Intelligence (Loo SK, 2012, 57 SNPs) Interferon alpha levels in systemic lupus erythematosus (Kariuki SN, 2014, 8 SNPs) Interleukin-18 levels (He M, 2010, 2 SNPs) Interstitial lung disease (18 SNPs from 2 studies) Interstitial lung disease (Fingerlin TE, 2013, 16 SNPs) Interstitial lung disease (Nyberg F, 2011, 2 SNPs) Intracerebral hemorrhage (Woo D, 2014, 1 SNP) Intracranial aneurysm (12 SNPs from 5 studies) Intracranial aneurysm (Bilguvar K, 2008, 4 SNPs) Intracranial aneurysm (Foroud T, 2012, 1 SNP) Intracranial aneurysm (Foroud T, 2014, 4 SNPs) Intracranial aneurysm (Low SK, 2012, 4 SNPs) Intracranial aneurysm (Yasuno K, 2010, 6 SNPs) Intracranial volume (Ikram MA, 2012, 2 SNPs) Intraocular pressure (18 SNPs from 5 studies) Intraocular pressure (Hysi PG, 2014, 8 SNPs) Intraocular pressure (Nag A, 2014, 1 SNP) Intraocular pressure (Ozel AB, 2013, 10 SNPs) Intraocular pressure (The Blue Mountains Eye Study (BMES) and The Wellcome Trust Case Control Consortium 2 (WTCCC2), 2013, 1 SNP) Intraocular pressure (van Koolwijk LM, 2012, 2 SNPs) Iris characteristics (Larsson M, 2011, 7 SNPs) Iris color (Kayser M, 2008, 1 SNP) Iron deficiency (McLaren CE, 2011, 1 SNP) Iron levels (Tanaka T, 2009, 1 SNP) Iron status biomarkers (23 SNPs from 6 studies) Iron status biomarkers (Benyamin B, 2008, 27 SNPs) Iron status biomarkers (Benyamin B, 2009, 4 SNPs) Iron status biomarkers (ferritin levels) (Benyamin B, 2014, 5 SNPs) Iron status biomarkers (iron levels) (Benyamin B, 2014, 5 SNPs) Iron status biomarkers (Li J, 2014, 3 SNPs) Iron status biomarkers (McLaren CE, 2011, 9 SNPs) Iron status biomarkers (Oexle K, 2010, 5 SNPs) Iron status biomarkers (Pichler I, 2011, 5 SNPs) Iron status biomarkers (transferrin levels) (Benyamin B, 2014, 9 SNPs) Iron status biomarkers (transferrin saturation) (Benyamin B, 2014, 6 SNPs) Irritable bowel syndrome (4 SNPs from 2 studies) Irritable bowel syndrome (Ek WE, 2014, 2 SNPs) Irritable bowel syndrome (Holliday EG, 2014, 2 SNPs) Ischemic stroke (Dichgans M, 2013, 6 SNPs) Job-related exhaustion (Sulkava S, 2013, 1 SNP) Kashin-Beck disease (Zhang F, 2014, 1 SNP) Kawasaki disease (16 SNPs from 6 studies) Kawasaki disease (Burgner D, 2009, 2 SNPs) Kawasaki disease (Khor CC, 2011, 2 SNPs) Kawasaki disease (Kim JJ, 2011, 2 SNPs) Kawasaki disease (Lee YC, 2012, 6 SNPs) Kawasaki disease (Onouchi Y, 2012, 5 SNPs) Kawasaki disease (Tsai FJ, 2011, 2 SNPs) Keloid (Nakashima M, 2010, 4 SNPs) Kidney function decline traits (Gorski M, 2014, 8 SNPs) Kidney stones (Thorleifsson G, 2009, 1 SNP) Knee osteoarthritis (3 SNPs from 2 studies) Knee osteoarthritis (Nakajima M, 2010, 1 SNP) Knee osteoarthritis (Valdes AM, 2008, 2 SNPs) L-arginine levels (Luneburg N, 2014, 1 SNP) Large artery stroke (Dichgans M, 2013, 9 SNPs) Large B-cell lymphoma (Kumar V, 2011, 2 SNPs) Laryngeal squamous cell carcinoma (Wei Q, 2014, 6 SNPs) LDL (oxidized) (Makela KM, 2012, 1 SNP) LDL cholesterol (69 SNPs from 15 studies) LDL cholesterol (Aulchenko YS, 2008, 12 SNPs) LDL cholesterol (Burkhardt R, 2008, 2 SNPs) LDL cholesterol (Coram MA, 2013, 5 SNPs) LDL cholesterol (Kathiresan S, 2008, 11 SNPs) LDL cholesterol (Kathiresan S, 2008, 7 SNPs) LDL cholesterol (Lettre G, 2011, 17 SNPs) LDL cholesterol (Rasmussen-Torvik LJ, 2012, 1 SNP) LDL cholesterol (Sabatti C, 2008, 7 SNPs) LDL cholesterol (Sandhu MS, 2008, 3 SNPs) LDL cholesterol (Shen H, 2010, 2 SNPs) LDL cholesterol (Teslovich TM, 2010, 37 SNPs) LDL cholesterol (Wallace C, 2008, 3 SNPs) LDL cholesterol (Waterworth DM, 2010, 11 SNPs) LDL cholesterol (Willer CJ, 2008, 7 SNPs) LDL cholesterol (Willer CJ, 2013, 59 SNPs) Lean body mass and age at menarche (combined) (Hai R, 2012, 1 SNP) Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction) (Hohman TJ, 2014, 4 SNPs) Left ventricular mass (Arnett DK, 2009, 2 SNPs) Leishmaniasis (visceral) (Fakiola M, 2013, 1 SNP) Lentiform nucleus volume (Hibar DP, 2012, 14 SNPs) Leprosy (6 SNPs from 3 studies) Leprosy (Liu H, 2015, 22 SNPs) Leprosy (Zhang F, 2011, 4 SNPs) Leprosy (Zhang FR, 2009, 6 SNPs) Lewy body disease (Beecham GW, 2014, 31 SNPs) Life threatening arrhythmia (Murray SS, 2012, 2 SNPs) Lifetime average cigarettes per day in chronic obstructive pulmonary disease (Siedlinski M, 2011, 11 SNPs) Lipid levels in hepatitis C treatment (Clark PJ, 2012, 1 SNP) Lipid metabolism phenotypes (63 SNPs from 2 studies) Lipid metabolism phenotypes (Chasman DI, 2009, 73 SNPs) Lipid metabolism phenotypes (Kettunen J, 2012, 18 SNPs) Lipid traits (22 SNPs from 4 studies) Lipid traits (Keller M, 2013, 6 SNPs) Lipid traits (Surakka I, 2011, 1 SNP) Lipid traits (Wu Y, 2013, 6 SNPs) Lipid traits (Zhou L, 2013, 18 SNPs) Lipoprotein (a) - cholesterol levels (Lu W, 2015, 15 SNPs) Lipoprotein-associated phospholipase A2 activity and mass (11 SNPs from 3 studies) Lipoprotein-associated phospholipase A2 activity and mass (Chu AY, 2012, 9 SNPs) Lipoprotein-associated phospholipase A2 activity and mass (Grallert H, 2011, 7 SNPs) Lipoprotein-associated phospholipase A2 activity and mass (Suchindran S, 2010, 5 SNPs) Lipoprotein-associated phospholipase A2 activity change in response to statin therapy (Chu AY, 2012, 7 SNPs) Liver enzyme levels (alanine transaminase) (15 SNPs from 2 studies) Liver enzyme levels (alanine transaminase) (Chambers JC, 2011, 4 SNPs) Liver enzyme levels (alanine transaminase) (Park TJ, 2013, 11 SNPs) Liver enzyme levels (alkaline phosphatase) (Chambers JC, 2011, 14 SNPs) Liver enzyme levels (aspartate transaminase) (Park TJ, 2013, 8 SNPs) Liver enzyme levels (gamma-glutamyl transferase) (Chambers JC, 2011, 26 SNPs) Liver enzyme levels (Yuan X, 2008, 11 SNPs) Lobular breast cancer (menopausal hormone therapy interaction) (Rudolph A, 2013, 2 SNPs) Local histogram emphysema pattern (Castaldi PJ, 2014, 25 SNPs) Longevity (42 SNPs from 5 studies) Longevity (85 years and older) (Deelen J, 2014, 4 SNPs) Longevity (90 years and older) (10 SNPs from 2 studies) Longevity (90 years and older) (Broer L, 2014, 7 SNPs) Longevity (90 years and older) (Deelen J, 2014, 3 SNPs) Longevity (Deelen J, 2011, 1 SNP) Longevity (Malovini A, 2011, 1 SNP) Longevity (Nebel A, 2011, 1 SNP) Longevity (Newman AB, 2010, 1 SNP) Longevity (Yashin AI, 2010, 39 SNPs) Lp (a) levels (2 SNPs from 2 studies) Lp (a) levels (Ober C, 2009, 1 SNP) Lp (a) levels (Qi Q, 2011, 4 SNPs) Lumiracoxib-related liver injury (Singer JB, 2010, 1 SNP) Lung adenocarcinoma (6 SNPs from 4 studies) Lung adenocarcinoma (Hsiung CA, 2010, 1 SNP) Lung adenocarcinoma (Landi MT, 2009, 5 SNPs) Lung adenocarcinoma (Miki D, 2010, 2 SNPs) Lung adenocarcinoma (Shiraishi K, 2012, 4 SNPs) Lung cancer (21 SNPs from 11 studies) Lung cancer (Amos CI, 2008, 3 SNPs) Lung cancer (Broderick P, 2009, 7 SNPs) Lung Cancer (DNA repair capacity) (Wang LE, 2012, 2 SNPs) Lung cancer (Hu Z, 2011, 4 SNPs) Lung cancer (Hung RJ, 2008, 1 SNP) Lung cancer (Lan Q, 2012, 7 SNPs) Lung cancer (Li Y, 2010, 1 SNP) Lung cancer (Liu P, 2008, 1 SNP) Lung cancer (McKay JD, 2008, 2 SNPs) Lung cancer (smoking interaction) (Zhang R, 2014, 2 SNPs) Lung cancer (Timofeeva MN, 2012, 1 SNP) Lung cancer (Wang Y, 2008, 3 SNPs) Lung cancer (Wang Y, 2014, 5 SNPs) Lung cancer-asbestos exposure interaction (Wei S, 2012, 2 SNPs) Lung function (forced expiratory flow between 25% and 75% of forced vital capacity) (Ong BA, 2013, 12 SNPs) Lung function (forced expiratory volume in 1 second to forced vital capacity ratio) (Ong BA, 2013, 5 SNPs) Lung function (forced expiratory volume in 1 second) (Ong BA, 2013, 9 SNPs) Lung function (forced vital capacity) (Ong BA, 2013, 9 SNPs) Lupus nephritis in systemic lupus erythematosus (Chung SA, 2014, 17 SNPs) Lymphocyte counts (Cusanovich DA, 2012, 2 SNPs) Lymphoma (Vijai J, 2013, 13 SNPs) Magnesium levels (Meyer TE, 2010, 9 SNPs) Major CVD (Larson MG, 2007, 1 SNP) Major depressive disorder (82 SNPs from 10 studies) Major depressive disorder (Aragam N, 2011, 5 SNPs) Major depressive disorder (broad) (Shyn SI, 2009, 9 SNPs) Major depressive disorder (GENDEP Investigators, 2013, 49 SNPs) Major depressive disorder (Kohli MA, 2011, 1 SNP) Major depressive disorder (Lewis CM, 2010, 4 SNPs) Major depressive disorder (Muglia P, 2008, 1 SNP) Major depressive disorder (Power RA, 2013, 2 SNPs) Major depressive disorder (Rietschel M, 2010, 3 SNPs) Major depressive disorder (Shi J, 2010, 9 SNPs) Major depressive disorder (Sullivan, 2012, 5 SNPs) Major depressive disorder (Wray NR, 2010, 4 SNPs) Major mood disorders (McMahon FJ, 2010, 1 SNP) Malaria (10 SNPs from 3 studies) Malaria (Band G, 2013, 6 SNPs) Malaria (Jallow M, 2009, 3 SNPs) Malaria (Timmann C, 2012, 4 SNPs) Male fertility (Kosova G, 2012, 5 SNPs) Male infertility (Aston KI, 2009, 5 SNPs) Male-pattern baldness (8 SNPs from 4 studies) Male-pattern baldness (Brockschmidt FF, 2011, 2 SNPs) Male-pattern baldness (Hillmer AM, 2008, 1 SNP) Male-pattern baldness (Li R, 2012, 8 SNPs) Male-pattern baldness (Richards JB, 2008, 2 SNPs) Mammographic density (dense area) (Lindstrom S, 2014, 12 SNPs) Mammographic density (Fernandez-Navarro P, 2014, 5 SNPs) Mammographic density (non-dense area) (Lindstrom S, 2014, 8 SNPs) Marginal zone lymphoma (Vijai J, 2015, 4 SNPs) Mathematical ability in children with dyslexia (Ludwig KU, 2013, 1 SNP) Matrix metalloproteinase levels (Cheng YC, 2009, 4 SNPs) Maximal oxygen uptake response (Ahmetov I, 2014, 4 SNPs) Mean arterial pressure (alcohol consumption interaction) (Simino J, 2013, 9 SNPs) Mean corpuscular hemoglobin (18 SNPs from 3 studies) Mean corpuscular hemoglobin (Ganesh SK, 2009, 9 SNPs) Mean corpuscular hemoglobin (Kamatani Y, 2010, 15 SNPs) Mean corpuscular hemoglobin (Li J, 2012, 10 SNPs) Mean corpuscular hemoglobin concentration (11 SNPs from 2 studies) Mean corpuscular hemoglobin concentration (Kamatani Y, 2010, 7 SNPs) Mean corpuscular hemoglobin concentration (Li J, 2012, 6 SNPs) Mean corpuscular volume (25 SNPs from 3 studies) Mean corpuscular volume (Ganesh SK, 2009, 17 SNPs) Mean corpuscular volume (Kamatani Y, 2010, 17 SNPs) Mean corpuscular volume (Li J, 2012, 10 SNPs) Mean forced vital capacity from 2 exams (Wilk JB, 2007, 2 SNPs) Mean platelet volume (37 SNPs from 6 studies) Mean platelet volume (Gieger C, 2011, 29 SNPs) Mean platelet volume (Meisinger C, 2008, 3 SNPs) Mean platelet volume (Qayyum R, 2012, 13 SNPs) Mean platelet volume (Shameer K, 2013, 11 SNPs) Mean platelet volume (Soranzo N, 2009, 1 SNP) Mean platelet volume (Soranzo N, 2009, 15 SNPs) Medication adherence in chronic diseases (Seo I, 2014, 2 SNPs) Melanoma (19 SNPs from 8 studies) Melanoma (Amos CI, 2011, 1 SNP) Melanoma (Barrett JH, 2011, 10 SNPs) Melanoma (Bishop DT, 2009, 5 SNPs) Melanoma (Brown KM, 2008, 1 SNP) Melanoma (Iles MM, 2013, 1 SNP) Melanoma (Macgregor S, 2011, 2 SNPs) Melanoma (Song F, 2014, 6 SNPs) Melanoma (Teerlink C, 2011, 1 SNP) Memory performance (Luksys G, 2014, 1 SNP) Menarche (age at onset) (134 SNPs from 7 studies) Menarche (age at onset) (Demerath EW, 2013, 15 SNPs) Menarche (age at onset) (Elks CE, 2010, 42 SNPs) Menarche (age at onset) (Ong KK, 2009, 1 SNP) Menarche (age at onset) (Perry JR, 2009, 2 SNPs) Menarche (age at onset) (Perry JR, 2014, 122 SNPs) Menarche (age at onset) (Sulem P, 2009, 1 SNP) Menarche (age at onset) (Tanikawa C, 2013, 8 SNPs) Menarche and menopause (age at onset) (He C, 2009, 6 SNPs) Meningioma (Dobbins SE, 2011, 1 SNP) Meningococcal disease (Davila S, 2010, 1 SNP) Menopause (age at onset) (30 SNPs from 4 studies) Menopause (age at onset) (Perry JR, 2013, 8 SNPs) Menopause (age at onset) (Pyun JA, 2013, 2 SNPs) Menopause (age at onset) (Stolk L, 2009, 13 SNPs) Menopause (age at onset) (Stolk L, 2012, 19 SNPs) Mesial temporal lobe epilepsy with hippocampal sclerosis (Kasperaviciute D, 2013, 2 SNPs) Metabolic syndrome (39 SNPs from 4 studies) Metabolic syndrome (bivariate traits) (Kraja AT, 2011, 16 SNPs) Metabolic syndrome (Kraja AT, 2011, 5 SNPs) Metabolic syndrome (Kristiansson K, 2012, 22 SNPs) Metabolic syndrome (Shim U, 2014, 2 SNPs) Metabolic syndrome (Zabaneh D, 2010, 18 SNPs) Metabolic traits (46 SNPs from 2 studies) Metabolic traits (Sabatti C, 2008, 11 SNPs) Metabolic traits (Suhre K, 2011, 37 SNPs) Metabolite levels (X-11787) (Yu B, 2013, 29 SNPs) Metabolite levels (5-HIAA) (Luykx JJ, 2013, 13 SNPs) Metabolite levels (5-HIAA/ MHPG Ratio) (Luykx JJ, 2013, 11 SNPs) Metabolite levels (79 SNPs from 8 studies) Metabolite levels (Dihydroxy docosatrienoic acid) (Yu B, 2013, 20 SNPs) Metabolite levels (Gieger C, 2008, 16 SNPs) Metabolite levels (Hong MG, 2013, 9 SNPs) Metabolite levels (HVA) (Luykx JJ, 2013, 13 SNPs) Metabolite levels (HVA-5-HIAA Factor score) (Luykx JJ, 2013, 12 SNPs) Metabolite levels (HVA/5-HIAA ratio) (Luykx JJ, 2013, 9 SNPs) Metabolite levels (HVA/MHPG ratio) (Luykx JJ, 2013, 25 SNPs) Metabolite levels (Illig T, 2009, 5 SNPs) Metabolite levels (Inouye M, 2012, 34 SNPs) Metabolite levels (Kettunen J, 2012, 13 SNPs) Metabolite levels (Kim YJ, 2011, 18 SNPs) Metabolite levels (MHPG) (Luykx JJ, 2013, 20 SNPs) Metabolite levels (Nicholson G, 2011, 3 SNPs) Metabolite levels (Pyroglutamine) (Yu B, 2013, 23 SNPs) Metabolite levels (Xie W, 2013, 6 SNPs) Methamphetamine dependence (Ikeda M, 2013, 1 SNP) Methotrexate clearance (acute lymphoblastic leukemia) (Ramsey LB, 2012, 1 SNP) Methotrexate phramacokinetics (acute lymphoblastic leukemia) (Trevino LR, 2009, 21 SNPs) Migraine (63 SNPs from 5 studies) Migraine (Anttila V, 2010, 1 SNP) Migraine (Anttila V, 2013, 59 SNPs) Migraine (Chasman DI, 2011, 3 SNPs) Migraine (Freilinger T, 2012, 10 SNPs) Migraine (Ligthart L, 2011, 2 SNPs) Migraine - clinic-based (Anttila V, 2013, 37 SNPs) Migraine with aura (Anttila V, 2013, 23 SNPs) Migraine without aura (Anttila V, 2013, 32 SNPs) Mitochondrial DNA levels (Lopez S, 2014, 21 SNPs) Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection (Zignego AL, 2014, 2 SNPs) Molar-incisor hypomineralization (Kuhnisch J, 2013, 5 SNPs) Monocyte chemoattractant protein-1 (Voruganti VS, 2012, 3 SNPs) Monocyte count (12 SNPs from 2 studies) Monocyte count (Crosslin DR, 2013, 6 SNPs) Monocyte count (Keller MF, 2014, 11 SNPs) Monocyte early outgrowth colony forming units (Shaw SY, 2011, 3 SNPs) Morbidity-free survival (Lunetta KL, 2007, 5 SNPs) Morphine dose requirement in tonsillectomy and adenoidectomy surgery (Cook-Sather SD, 2014, 1 SNP) Mortality in heart failure (Morrison AC, 2010, 11 SNPs) Moyamoya disease (Kamada F, 2010, 1 SNP) MRI atrophy measures (Furney SJ, 2010, 13 SNPs) Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma) (Jin G, 2012, 7 SNPs) Multiple myeloma (9 SNPs from 2 studies) Multiple myeloma (Broderick P, 2011, 3 SNPs) Multiple myeloma (Chubb D, 2013, 6 SNPs) Multiple myeloma (hyperdiploidy) (Weinhold N, 2013, 14 SNPs) Multiple myeloma (IgH translocation) (Weinhold N, 2013, 25 SNPs) Multiple sclerosis (127 SNPs from 16 studies) Multiple sclerosis (age of onset) (Baranzini SE, 2008, 8 SNPs) Multiple sclerosis (Aulchenko YS, 2008, 1 SNP) Multiple sclerosis (Bahlo, 2009, 8 SNPs) Multiple sclerosis (Baranzini SE, 2008, 10 SNPs) Multiple sclerosis (Briggs FB, 2011, 6 SNPs) Multiple sclerosis (Comabella M, 2008, 1 SNP) Multiple sclerosis (De Jager PL, 2009, 15 SNPs) Multiple sclerosis (Gourraud PA, 2013, 16 SNPs) Multiple sclerosis (Hafler DA, 2007, 6 SNPs) Multiple sclerosis (Jakkula E, 2010, 2 SNPs) Multiple sclerosis (Martinelli-Boneschi F, 2012, 1 SNP) Multiple sclerosis (Matesanz F, 2012, 1 SNP) Multiple sclerosis (Nischwitz S, 2010, 4 SNPs) Multiple sclerosis (OCB status) (12 SNPs from 2 studies) Multiple sclerosis (OCB status) (Leone MA, 2013, 1 SNP) Multiple sclerosis (OCB status) (Mero IL, 2013, 11 SNPs) Multiple sclerosis (Patsopoulos NA, 2011, 19 SNPs) Multiple sclerosis (Sanna S, 2010, 2 SNPs) Multiple sclerosis (Sawcer S, 2011, 82 SNPs) Multiple sclerosis (severity) (12 SNPs from 2 studies) Multiple sclerosis (severity) (Baranzini SE, 2008, 11 SNPs) Multiple sclerosis (severity) (Brynedal B, 2010, 1 SNP) Multiple sclerosis (Wang JH, 2011, 3 SNPs) Multiple sclerosis or amyotrophic lateral sclerosis (Goris A, 2013, 1 SNP) Multiple sclerosis--Brain Glutamate Levels (Baranzini SE, 2010, 5 SNPs) Musician's dystonia (Lohmann K, 2013, 3 SNPs) Myasthenia gravis (Gregersen PK, 2012, 6 SNPs) Myeloproliferative neoplasms (Kilpivaara O, 2009, 1 SNP) Myocardial infarction (5 SNPs from 3 studies) Myocardial infarction (Aoki A, 2010, 1 SNP) Myocardial infarction (early onset) (Kathiresan S, 2009, 9 SNPs) Myocardial infarction (Helgadottir A, 2007, 1 SNP) Myocardial infarction (Hirokawa M, 2014, 4 SNPs) Myocardial infarction in coronary artery disease (Reilly MP, 2011, 1 SNP) Myopia (pathological) (81 SNPs from 7 studies) Myopia (pathological) (Fan Q, 2012, 4 SNPs) Myopia (pathological) (Li YJ, 2010, 1 SNP) Myopia (pathological) (Li Z, 2011, 2 SNPs) Myopia (pathological) (Meng W, 2012, 64 SNPs) Myopia (pathological) (Nakanishi H, 2009, 1 SNP) Myopia (pathological) (Shi Y, 2011, 1 SNP) Myopia (pathological) (Shi Y, 2013, 8 SNPs) Myopia (severe) (Khor CC, 2013, 2 SNPs) Myopia (Simpson CL, 2014, 4 SNPs) N-glycan levels (Lauc G, 2010, 8 SNPs) Narcolepsy (7 SNPs from 4 studies) Narcolepsy (age of onset) (Han F, 2013, 3 SNPs) Narcolepsy (Hallmayer J, 2009, 1 SNP) Narcolepsy (Han F, 2013, 5 SNPs) Narcolepsy (Hor H, 2010, 2 SNPs) Narcolepsy (Miyagawa T, 2008, 1 SNP) Narcolepsy (onset before 2009 H1N1 influenza pandemic) (Han F, 2013, 2 SNPs) Narcolepsy with cataplexy (Luca G, 2013, 4 SNPs) Nasopharyngeal carcinoma (8 SNPs from 3 studies) Nasopharyngeal carcinoma (Bei JX, 2010, 7 SNPs) Nasopharyngeal carcinoma (Ng CC, 2009, 1 SNP) Nasopharyngeal carcinoma (Tse KP, 2009, 3 SNPs) Natriuretic peptide levels (Del Greco M F, 2011, 3 SNPs) Neonatal lupus (Clancy RM, 2010, 5 SNPs) Nephrolithiasis (Urabe Y, 2012, 3 SNPs) Nephropathy (4 SNPs from 2 studies) Nephropathy (Feehally J, 2010, 1 SNP) Nephropathy (Gharavi AG, 2011, 5 SNPs) Nephrotic syndrome (acquired) (Okamoto K, 2011, 2 SNPs) Neuranatomic and neurocognitive phenotypes (Carless MA, 2011, 1 SNP) Neuritic plaque (Beecham GW, 2014, 20 SNPs) Neuroblastoma (6 SNPs from 3 studies) Neuroblastoma (Diskin SJ, 2012, 6 SNPs) Neuroblastoma (high-risk) (Capasso M, 2009, 1 SNP) Neuroblastoma (Maris JM, 2008, 1 SNP) Neuroblastoma (Wang K, 2010, 3 SNPs) Neurofibrillary tangles (Beecham GW, 2014, 22 SNPs) Neuropathic pain in type 2 diabetes (Meng W, 2014, 2 SNPs) Neuroticism (8 SNPs from 4 studies) Neuroticism (Aragam N, 2012, 1 SNP) Neuroticism (Calboli FC, 2010, 3 SNPs) Neuroticism (Shifman S, 2007, 1 SNP) Neuroticism (van den Oord EJ, 2008, 3 SNPs) Neutrophil count (30 SNPs from 3 studies) Neutrophil count (Keller MF, 2014, 9 SNPs) Neutrophil count (Okada Y, 2010, 2 SNPs) Neutrophil count (Ramsuran V, 2011, 20 SNPs) Neutrophil count in HIV-infection (Moore CB, 2015, 2 SNPs) Nevirapine-induced rash (Chantarangsu S, 2011, 3 SNPs) Nicotine dependence (4 SNPs from 3 studies) Nicotine dependence (Bierut LJ, 2006, 2 SNPs) Nicotine dependence (Rice JP, 2012, 1 SNP) Nicotine dependence (Thorgeirsson TE, 2008, 1 SNP) Nicotine glucouronidation (Patel Y, 2014, 2 SNPs) Nicotine use (McGue M, 2013, 6 SNPs) Nodular sclerosis Hodgkin lymphoma (Cozen W, 2011, 10 SNPs) Non-albumin protein levels (Osman W, 2012, 5 SNPs) Non-alcoholic fatty liver disease (Kitamoto T, 2013, 4 SNPs) Non-alcoholic fatty liver disease histology (AST) (Chalasani N, 2010, 6 SNPs) Non-alcoholic fatty liver disease histology (lobular) (Chalasani N, 2010, 13 SNPs) Non-alcoholic fatty liver disease histology (other) (20 SNPs from 2 studies) Non-alcoholic fatty liver disease histology (other) (Adams LA, 2012, 4 SNPs) Non-alcoholic fatty liver disease histology (other) (Chalasani N, 2010, 16 SNPs) Non-melanoma skin cancer (Zhang M, 2013, 4 SNPs) Non-obstructive azoospermia (5 SNPs from 2 studies) Non-obstructive azoospermia (Hu Z, 2011, 4 SNPs) Non-obstructive azoospermia (Zhao H, 2012, 1 SNP) Non-small cell lung cancer (17 SNPs from 3 studies) Non-small cell lung cancer (Ahn MJ, 2011, 1 SNP) Non-small cell lung cancer (Lee Y, 2012, 13 SNPs) Non-small cell lung cancer (recurrence rate) (Yoon KA, 2014, 6 SNPs) Non-small cell lung cancer (survival) (6 SNPs from 2 studies) Non-small cell lung cancer (survival) (Sato Y, 2010, 3 SNPs) Non-small cell lung cancer (survival) (Tang S, 2014, 3 SNPs) Non-small cell lung cancer (Yoon KA, 2010, 3 SNPs) Non-substance related behavioral disinhibition (McGue M, 2013, 4 SNPs) Non-word repetition (Luciano M, 2013, 5 SNPs) Nonalcoholic fatty liver disease (3 SNPs from 2 studies) Nonalcoholic fatty liver disease (Kawaguchi T, 2012, 5 SNPs) Nonalcoholic fatty liver disease (Speliotes EK, 2011, 1 SNP) Normalized brain volume (Baranzini SE, 2008, 5 SNPs) Obesity (88 SNPs from 7 studies) Obesity (Berndt SI, 2013, 66 SNPs) Obesity (Bradfield JP, 2012, 5 SNPs) Obesity (Dorajoo R, 2011, 1 SNP) Obesity (early onset extreme) (20 SNPs from 3 studies) Obesity (early onset extreme) (Hinney A, 2007, 1 SNP) Obesity (early onset extreme) (Scherag A, 2010, 5 SNPs) Obesity (early onset extreme) (Wheeler E, 2013, 18 SNPs) Obesity (extreme) (17 SNPs from 2 studies) Obesity (extreme) (Cotsapas C, 2009, 13 SNPs) Obesity (extreme) (Paternoster L, 2011, 4 SNPs) Obesity (Jiao H, 2011, 2 SNPs) Obesity (Kim HJ, 2012, 3 SNPs) Obesity (Meyre D, 2009, 5 SNPs) Obesity (Wang K, 2011, 14 SNPs) Obesity and osteoporosis (Liu YZ, 2009, 2 SNPs) Obesity-related traits (955 SNPs from 3 studies) Obesity-related traits (Comuzzie AG, 2012, 949 SNPs) Obesity-related traits (Melka MG, 2011, 5 SNPs) Obesity-related traits (Scuteri A, 2007, 3 SNPs) Obsessive-compulsive disorder (5 SNPs from 2 studies) Obsessive-compulsive disorder (Mattheisen M, 2014, 2 SNPs) Obsessive-compulsive disorder (Stewart SE, 2012, 3 SNPs) Odorant perception (β-damascenone) (McRae JF, 2013, 1 SNP) Odorant perception (β-ionone) (McRae JF, 2013, 1 SNP) Odorant perception (isobutyraldehyde) (McRae JF, 2013, 1 SNP) Oleic acid (18:1n-9) plasma levels (Wu JH, 2013, 9 SNPs) Opioid sensitivity (4 SNPs from 2 studies) Opioid sensitivity (Gelernter J, 2013, 3 SNPs) Opioid sensitivity (Nishizawa D, 2012, 1 SNP) Optic disc area (Khor CC, 2011, 4 SNPs) Optic disc parameters (Ramdas WD, 2010, 3 SNPs) Optic nerve measurement (cup area) (Macgregor S, 2010, 9 SNPs) Optic nerve measurement (cup-to-disc ratio) (Macgregor S, 2010, 4 SNPs) Optic nerve measurement (disc area) (Macgregor S, 2010, 7 SNPs) Optic nerve measurement (rim area) (Macgregor S, 2010, 6 SNPs) Orofacial clefts (47 SNPs from 5 studies) Orofacial clefts (Birnbaum S, 2009, 2 SNPs) Orofacial clefts (Grant SF, 2009, 2 SNPs) Orofacial clefts (interaction) (Beaty TH, 2011, 2 SNPs) Orofacial clefts (Ludwig KU, 2012, 31 SNPs) Orofacial clefts (Mangold E, 2009, 6 SNPs) Orofacial clefts (Shi M, 2012, 17 SNPs) Orthostatic hypotension (Hong KW, 2013, 5 SNPs) Ossification of the posterior longitudinal ligament of the spine (Nakajima M, 2014, 8 SNPs) Osteoarthritis (7 SNPs from 5 studies) Osteoarthritis (Castano Betancourt MC, 2012, 1 SNP) Osteoarthritis (Day-Williams AG, 2011, 1 SNP) Osteoarthritis (Evangelou E, 2010, 1 SNP) Osteoarthritis (hand, severe) (Styrkarsdottir U, 2014, 1 SNP) Osteoarthritis (hip) (Evangelou E, 2013, 5 SNPs) Osteoarthritis (Kerkhof HJ, 2010, 1 SNP) Osteoarthritis (Loughlin, 2012, 4 SNPs) Osteoarthritis biomarkers (Ramos YF, 2014, 5 SNPs) Osteonecrosis of the jaw (Sarasquete ME, 2008, 1 SNP) Osteoporosis (3 SNPs from 3 studies) Osteoporosis (Guo Y, 2010, 1 SNP) Osteoporosis (Hwang JY, 2013, 1 SNP) Osteoporosis (Kou I, 2011, 1 SNP) Osteoporosis-related phenotypes (8 SNPs from 2 studies) Osteoporosis-related phenotypes (Hsu YH, 2010, 7 SNPs) Osteoporosis-related phenotypes (Karasik D, 2010, 1 SNP) Osteoprotegerin levels (Kwan JS, 2014, 4 SNPs) Osteosarcoma (Savage SA, 2013, 6 SNPs) Other erythrocyte phenotypes (Ganesh SK, 2009, 4 SNPs) Otitis media (chronic/recurrent) (Allen EK, 2013, 1 SNP) Otosclerosis (Schrauwen I, 2009, 1 SNP) Ovarian cancer (17 SNPs from 5 studies) Ovarian cancer (Bolton KL, 2010, 2 SNPs) Ovarian cancer (Goode EL, 2010, 7 SNPs) Ovarian cancer (Pharoah PD, 2013, 17 SNPs) Ovarian cancer (Rafnar T, 2011, 1 SNP) Ovarian cancer (Song H, 2009, 1 SNP) Ovarian cancer in BRCA1 mutation carriers (Couch FJ, 2013, 7 SNPs) Ovarian reserve (Schuh-Huerta SM, 2011, 7 SNPs) Overweight status (Scannell Bryan M, 2014, 3 SNPs) P wave duration (Verweij N, 2014, 3 SNPs) Paclitaxel-induced neuropathy (Leandro-Garcia LJ, 2013, 10 SNPs) Paget's disease (9 SNPs from 2 studies) Paget's disease (Albagha OM, 2010, 4 SNPs) Paget's disease (Albagha OM, 2011, 9 SNPs) Pain (4 SNPs from 2 studies) Pain (Kim H, 2009, 3 SNPs) Pain (Peters MJ, 2012, 1 SNP) Palmitic acid (16:0) plasma levels (Wu JH, 2013, 12 SNPs) Palmitoleic acid (16:1n-7) plasma levels (Wu JH, 2013, 15 SNPs) Pancreatic cancer (42 SNPs from 6 studies) Pancreatic cancer (Amundadottir L, 2009, 1 SNP) Pancreatic cancer (Low SK, 2010, 17 SNPs) Pancreatic cancer (Petersen GM, 2010, 3 SNPs) Pancreatic cancer (Wolpin BM, 2014, 10 SNPs) Pancreatic cancer (Wu C, 2011, 11 SNPs) Pancreatic cancer (Wu C, 2012, 7 SNPs) Pancreatitis (Whitcomb DC, 2012, 5 SNPs) Panic disorder (Otowa T, 2009, 17 SNPs) Paraoxonase activity (Tang WH, 2012, 2 SNPs) Parasitemia in Tripanosoma cruzi seropositivity (Deng X, 2013, 24 SNPs) Parent of origin effect on language impairment (paternal) (Nudel R, 2014, 4 SNPs) Parkinson's disease (51 SNPs from 17 studies) Parkinson's disease (age of onset) (Latourelle JC, 2009, 5 SNPs) Parkinson's disease (Davis MF, 2013, 3 SNPs) Parkinson's disease (Do CB, 2011, 10 SNPs) Parkinson's disease (Edwards TL, 2010, 6 SNPs) Parkinson's disease (familial) (Pankratz N, 2008, 1 SNP) Parkinson's disease (Fung HC, 2006, 3 SNPs) Parkinson's disease (Hamza TH, 2010, 4 SNPs) Parkinson's disease (Hill-Burns EM, 2014, 8 SNPs) Parkinson's disease (Lill CM, 2012, 5 SNPs) Parkinson's disease (Liu X, 2011, 3 SNPs) Parkinson's disease (Maraganore DM, 2005, 1 SNP) Parkinson's disease (motor and cognition) (Chung SJ, 2012, 5 SNPs) Parkinson's disease (Nalls MA, 2011, 10 SNPs) Parkinson's disease (Nalls MA, 2014, 26 SNPs) Parkinson's disease (Pankratz N, 2012, 17 SNPs) Parkinson's disease (Saad M, 2010, 3 SNPs) Parkinson's disease (Satake W, 2009, 4 SNPs) Parkinson's disease (Simon-Sanchez J, 2009, 10 SNPs) Parkinson's disease (Spencer CC, 2010, 3 SNPs) Parkinson's disease (Vacic V, 2014, 4 SNPs) Partial epilepsies (Kasperaviciute D, 2010, 6 SNPs) PCA3 expression level (Chen Z, 2013, 4 SNPs) Percent mammographic density (6 SNPs from 3 studies) Percent mammographic density (Lindstrom S, 2011, 1 SNP) Percent mammographic density (Lindstrom S, 2014, 5 SNPs) Percent mammographic density (Stevens KN, 2012, 1 SNP) Pericardial fat (Fox CS, 2012, 1 SNP) Periodontal disease-related phenotypes (Shaffer JR, 2013, 10 SNPs) Periodontal microbiota (Divaris K, 2012, 16 SNPs) Periodontitis (4 SNPs from 2 studies) Periodontitis (CDC/AAP) (Teumer A, 2013, 28 SNPs) Periodontitis (Divaris K, 2013, 3 SNPs) Periodontitis (DPAL) (Teumer A, 2013, 15 SNPs) Periodontitis (Mean PAL) (Teumer A, 2013, 37 SNPs) Periodontitis (PAL4Q3) (Teumer A, 2013, 18 SNPs) Periodontitis (Schaefer AS, 2009, 1 SNP) Peripheral artery disease (5 SNPs from 2 studies) Peripheral artery disease (Koriyama H, 2010, 2 SNPs) Peripheral artery disease (Kullo IJ, 2014, 3 SNPs) Permanent tooth development (Geller F, 2011, 4 SNPs) Personality dimensions (22 SNPs from 4 studies) Personality dimensions (de Moor MH, 2010, 2 SNPs) Personality dimensions (Kim HN, 2013, 8 SNPs) Personality dimensions (Terracciano A, 2008, 5 SNPs) Personality dimensions (Verweij KJ, 2010, 7 SNPs) Personality traits in bipolar disorder (Alliey-Rodriguez N, 2011, 7 SNPs) Phospholipid levels (plasma) (18 SNPs from 2 studies) Phospholipid levels (plasma) (Demirkan A, 2012, 25 SNPs) Phospholipid levels (plasma) (Lemaitre RN, 2011, 50 SNPs) Phosphorus levels (Kestenbaum B, 2010, 5 SNPs) Phytosterol levels (Teupser D, 2010, 3 SNPs) Pit-and-Fissure caries (22 SNPs from 2 studies) Pit-and-Fissure caries (Zeng Z, 2013, 8 SNPs) Pit-and-Fissure caries (Zeng Z, 2014, 14 SNPs) Plasma amyloid beta peptide concentrations (ABx-40) (Chouraki V, 2014, 10 SNPs) Plasma amyloid beta peptide concentrations (ABx-42) (Chouraki V, 2014, 8 SNPs) Plasma cystastin c levels in acute coronary syndrome (Akerblom A, 2014, 2 SNPs) Plasma homocysteine levels (post-methionine load test) (Williams SR, 2014, 5 SNPs) Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid) (Guan W, 2014, 6 SNPs) Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid) (Guan W, 2014, 8 SNPs) Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid) (Guan W, 2014, 8 SNPs) Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid) (Guan W, 2014, 10 SNPs) Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) (Guan W, 2014, 8 SNPs) Plasma plasminogen activator levels (Huang J, 2014, 5 SNPs) Plasma plasminogen levels (Ma Q, 2014, 4 SNPs) Plasma renin activity levels (Lieb W, 2014, 3 SNPs) Plasma thyroid-stimulating hormone levels (Kwak SH, 2014, 3 SNPs) Plasminogen activator inhibitor type 1 levels (PAI-1) (Huang J, 2012, 4 SNPs) Platelet aggregation (Johnson AD, 2010, 15 SNPs) Platelet counts (55 SNPs from 6 studies) Platelet counts (Gieger C, 2011, 56 SNPs) Platelet counts (Kamatani Y, 2010, 7 SNPs) Platelet counts (Li J, 2012, 8 SNPs) Platelet counts (Oh JH, 2014, 3 SNPs) Platelet counts (Ramsuran V, 2011, 10 SNPs) Platelet counts (Shameer K, 2013, 8 SNPs) Platelet function and related traits (Guerrero JA, 2011, 1 SNP) Pneumoconiosis in silica exposure (Chu M, 2014, 3 SNPs) Political ideology (Hatemi PK, 2014, 19 SNPs) Polycystic ovary syndrome (15 SNPs from 3 studies) Polycystic ovary syndrome (Chen ZJ, 2010, 5 SNPs) Polycystic ovary syndrome (Lee H, 2015, 3 SNPs) Polycystic ovary syndrome (Shi Y, 2012, 11 SNPs) Post-traumatic stress disorder (16 SNPs from 3 studies) Post-traumatic stress disorder (asjusted for relatedness) (Xie P, 2013, 19 SNPs) Post-traumatic stress disorder (Nievergelt CM, 2014, 7 SNPs) Post-traumatic stress disorder (Wolf EJ, 2014, 7 SNPs) Post-traumatic stress disorder (Xie P, 2013, 2 SNPs) PR interval (20 SNPs from 5 studies) PR interval (Butler AM, 2012, 8 SNPs) PR interval (Hong KW, 2014, 5 SNPs) PR interval (Jeff JM, 2013, 9 SNPs) PR interval (Pfeufer A, 2010, 9 SNPs) PR interval (Smith JG, 2011, 5 SNPs) PR interval in Tripanosoma cruzi seropositivity (Deng X, 2013, 102 SNPs) PR segment (Verweij N, 2014, 8 SNPs) Preeclampsia (Zhao L, 2013, 18 SNPs) Premature ovarian failure (Qin Y, 2011, 1 SNP) Preschool internalizing problems (Benke KS, 2014, 13 SNPs) Presence of antiphospholipid antibodies (Kamboh MI, 2013, 13 SNPs) Primary biliary cirrhosis (19 SNPs from 4 studies) Primary biliary cirrhosis (Hirschfield GM, 2009, 13 SNPs) Primary biliary cirrhosis (Liu X, 2010, 6 SNPs) Primary biliary cirrhosis (Mells GF, 2011, 21 SNPs) Primary biliary cirrhosis (Nakamura M, 2012, 7 SNPs) Primary sclerosing cholangitis (Melum E, 2010, 2 SNPs) Primary tooth development (number of teeth) (13 SNPs from 2 studies) Primary tooth development (number of teeth) (Fatemifar G, 2013, 11 SNPs) Primary tooth development (number of teeth) (Pillas D, 2010, 9 SNPs) Primary tooth development (time to first tooth eruption) (13 SNPs from 2 studies) Primary tooth development (time to first tooth eruption) (Fatemifar G, 2013, 13 SNPs) Primary tooth development (time to first tooth eruption) (Pillas D, 2010, 6 SNPs) Prion diseases (Mead S, 2011, 11 SNPs) Progranulin levels (Carrasquillo MM, 2010, 1 SNP) Progressive supranuclear palsy (Hoglinger GU, 2011, 11 SNPs) Proinsulin levels (Strawbridge RJ, 2011, 10 SNPs) Prostate cancer (106 SNPs from 22 studies) Prostate cancer (Al Olama AA, 2014, 41 SNPs) Prostate cancer (Amin Al Olama A, 2012, 4 SNPs) Prostate cancer (Cheng I, 2012, 8 SNPs) Prostate cancer (early onset) (Lange EM, 2014, 9 SNPs) Prostate cancer (Eeles RA, 2008, 12 SNPs) Prostate cancer (Eeles RA, 2009, 19 SNPs) Prostate cancer (Eeles RA, 2013, 23 SNPs) Prostate cancer (gene x gene interaction) (Tao S, 2012, 51 SNPs) Prostate cancer (Gudmundsson J, 2007, 2 SNPs) Prostate cancer (Gudmundsson J, 2007, 2 SNPs) Prostate cancer (Gudmundsson J, 2008, 2 SNPs) Prostate cancer (Gudmundsson J, 2009, 8 SNPs) Prostate cancer (Gudmundsson J, 2012, 1 SNP) Prostate cancer (Haiman CA, 2011, 1 SNP) Prostate cancer (Knipe DW, 2014, 6 SNPs) Prostate cancer (Kote-Jarai Z, 2011, 9 SNPs) Prostate cancer (Murabito JM, 2007, 5 SNPs) Prostate cancer (Nam RK, 2011, 2 SNPs) Prostate cancer (Schumacher FR, 2011, 14 SNPs) Prostate cancer (Sun J, 2009, 1 SNP) Prostate cancer (Takata R, 2010, 11 SNPs) Prostate cancer (Thomas G, 2008, 7 SNPs) Prostate cancer (Xu J, 2012, 3 SNPs) Prostate cancer (Yeager M, 2007, 2 SNPs) Prostate-specific antigen levels (4 SNPs from 4 studies) Prostate-specific antigen levels (Jin G, 2013, 2 SNPs) Prostate-specific antigen levels (Kim S, 2014, 5 SNPs) Prostate-specific antigen levels (Sun J, 2012, 3 SNPs) Prostate-specific antigen levels (Terao C, 2014, 2 SNPs) Protein biomarker (de Boer RA, 2012, 2 SNPs) Protein C levels (3 SNPs from 2 studies) Protein C levels (Munir MS, 2014, 4 SNPs) Protein C levels (Tang W, 2010, 4 SNPs) Protein quantitative trait loci (Melzer D, 2008, 49 SNPs) Prothrombin time (Tang W, 2012, 2 SNPs) Psoriasis (24 SNPs from 7 studies) Psoriasis (Capon F, 2008, 2 SNPs) Psoriasis (Ellinghaus E, 2010, 3 SNPs) Psoriasis (Liu Y, 2008, 3 SNPs) Psoriasis (Nair RP, 2009, 8 SNPs) Psoriasis (Strange A, 2010, 17 SNPs) Psoriasis (Stuart PE, 2010, 8 SNPs) Psoriasis (Zhang XJ, 2009, 3 SNPs) Psoriatic arthritis (5 SNPs from 2 studies) Psoriatic arthritis (Ellinghaus E, 2011, 2 SNPs) Psoriatic arthritis (Huffmeier U, 2010, 3 SNPs) Psychosis (atypical) (Kanazawa T, 2013, 10 SNPs) Psychosis (methamphetamine induced) (Ikeda M, 2013, 1 SNP) Psychosis and Alzheimer's disease (Hollingworth P, 2011, 11 SNPs) Psychosis in Alzheimer's disease (Hollingworth P, 2011, 8 SNPs) Pubertal anthropometrics (Cousminer DL, 2013, 25 SNPs) Puberty onset (breast development) (Cousminer DL, 2014, 2 SNPs) Puberty onset (Cousminer DL, 2014, 2 SNPs) Puberty onset (genital enlargement) (Cousminer DL, 2014, 1 SNP) Pulmonary arterial hypertension (without BMPR2 mutations) (Germain M, 2013, 1 SNP) Pulmonary artery enlargement and chronic obstructive pulmonary disease (Lee JH, 2015, 1 SNP) Pulmonary artery enlargement in chronic obstructive pulmonary disease (Lee JH, 2015, 2 SNPs) Pulmonary emphysema (Manichaikul A, 2014, 3 SNPs) Pulmonary function (55 SNPs from 6 studies) Pulmonary function (Hancock DB, 2009, 8 SNPs) Pulmonary function (interaction) (Hancock DB, 2012, 53 SNPs) Pulmonary function (Repapi E, 2009, 7 SNPs) Pulmonary function (Soler Artigas M, 2011, 34 SNPs) Pulmonary function (Wilk JB, 2007, 10 SNPs) Pulmonary function (Wilk JB, 2009, 1 SNP) Pulmonary function (Yao TC, 2013, 7 SNPs) Pulmonary function decline (Imboden M, 2012, 39 SNPs) Pulmonary function in asthmatics (10 SNPs from 2 studies) Pulmonary function in asthmatics (Li X, 2013, 4 SNPs) Pulmonary function in asthmatics (Wu K, 2014, 6 SNPs) Pulse pressure (alcohol consumption interaction) (Simino J, 2013, 4 SNPs) Pulse pressure in young-onset hypertension (Leu HB, 2014, 1 SNP) Pyoderma gangrenosum in inflammatory bowel disease (Weizman A, 2014, 7 SNPs) QRS duration (25 SNPs from 3 studies) QRS duration (Hong KW, 2014, 6 SNPs) QRS duration (Jeff JM, 2013, 9 SNPs) QRS duration (Sotoodehnia N, 2010, 12 SNPs) QRS duration in Tripanosoma cruzi seropositivity (Deng X, 2013, 38 SNPs) QT interval (85 SNPs from 9 studies) QT interval (Arking DE, 2006, 1 SNP) QT interval (Arking DE, 2014, 74 SNPs) QT interval (interaction) (Avery CL, 2013, 17 SNPs) QT interval (Jeff JM, 2013, 8 SNPs) QT interval (Kim JW, 2012, 3 SNPs) QT interval (Marroni F, 2009, 14 SNPs) QT interval (Newton-Cheh C, 2009, 13 SNPs) QT interval (Nolte IM, 2009, 2 SNPs) QT interval (Pfeufer A, 2009, 12 SNPs) QT interval (Smith JG, 2012, 29 SNPs) QT interval in Tripanosoma cruzi seropositivity (Deng X, 2013, 14 SNPs) Quantitative traits (Lowe JK, 2009, 33 SNPs) Radiation response (Niu N, 2010, 12 SNPs) Reading and spelling (Luciano M, 2013, 10 SNPs) Reading or mathematical ability (Davis OS, 2014, 2 SNPs) Recombination measurement (females) (Kong A, 2010, 1 SNP) Recombination measurement (Hinch AG, 2011, 5 SNPs) Recombination measurement (males) (Kong A, 2010, 1 SNP) Recombination rate (females) (Kong A, 2008, 1 SNP) Recombination rate (males) (Kong A, 2008, 1 SNP) Red blood cell count (Kamatani Y, 2010, 8 SNPs) Red blood cell fatty acid levels (Tintle NL, 2014, 13 SNPs) Red blood cell traits (49 SNPs from 5 studies) Red blood cell traits (Chen Z, 2013, 15 SNPs) Red blood cell traits (Ding K, 2013, 7 SNPs) Red blood cell traits (Kullo IJ, 2010, 13 SNPs) Red blood cell traits (Pistis G, 2013, 4 SNPs) Red blood cell traits (van der Harst P, 2012, 45 SNPs) Red vs non-red hair color (Sulem P, 2007, 1 SNP) Red vs. non-red hair color (Sulem P, 2008, 2 SNPs) Refractive astigmatism (Li Q, 2014, 17 SNPs) Refractive error (26 SNPs from 4 studies) Refractive error (Hysi PG, 2010, 1 SNP) Refractive error (Solouki AM, 2010, 1 SNP) Refractive error (Stambolian D, 2013, 1 SNP) Refractive error (Verhoeven VJ, 2013, 26 SNPs) Relative hand skill (Brandler WM, 2013, 3 SNPs) Relative hand skill in reading disability (Brandler WM, 2013, 10 SNPs) Renal cell carcinoma (10 SNPs from 4 studies) Renal cell carcinoma (Gudmundsson J, 2013, 3 SNPs) Renal cell carcinoma (Henrion M, 2012, 2 SNPs) Renal cell carcinoma (Purdue MP, 2010, 3 SNPs) Renal cell carcinoma (Wu X, 2011, 3 SNPs) Renal function and chronic kidney disease (Kottgen A, 2009, 4 SNPs) Renal function-related traits (BUN) (Okada Y, 2012, 15 SNPs) Renal function-related traits (eGRFcrea) (Okada Y, 2012, 10 SNPs) Renal function-related traits (sCR) (Okada Y, 2012, 9 SNPs) Renal function-related traits (urea) (Okada Y, 2012, 4 SNPs) Renal sinus fat (Foster MC, 2011, 8 SNPs) Renal transplant outcome (O'Brien RP, 2013, 4 SNPs) Resistin levels (4 SNPs from 2 studies) Resistin levels (Chung CM, 2014, 1 SNP) Resistin levels (Qi Q, 2012, 4 SNPs) Response to abacavir-containing treatment in HIV-1 infection (virologic failure) (Lehmann DS, 2015, 27 SNPs) Response to acetaminophen (hepatotoxicity) (Moyer AM, 2010, 5 SNPs) Response to alcohol consumption (flushing response) (Quillen EE, 2013, 3 SNPs) Response to amphetamines (Hart AB, 2012, 88 SNPs) Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy) (Turner ST, 2012, 5 SNPs) Response to angiotensin II receptor blocker therapy (Turner ST, 2012, 20 SNPs) Response to anti-depressant treatment in major depressive disorder (Clark SL, 2011, 22 SNPs) Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy) (Leger PD, 2014, 11 SNPs) Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy) (Leger PD, 2014, 13 SNPs) Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) (Leger PD, 2014, 16 SNPs) Response to anti-TNF alpha therapy in inflammatory bowel disease (Dubinsky MC, 2010, 4 SNPs) Response to anti-TNF treatment in rheumatoid arthritis (Cui J, 2013, 5 SNPs) Response to antidepressant treatment (citalopram) (Hunter AM, 2013, 3 SNPs) Response to antidepressants (9 SNPs from 2 studies) Response to antidepressants (Sasayama D, 2012, 1 SNP) Response to antidepressants (Uher R, 2010, 8 SNPs) Response to antineoplastic agents (Wade R, 2011, 9 SNPs) Response to antipsychotic therapy (extrapyramidal side effects) (18 SNPs from 2 studies) Response to antipsychotic therapy (extrapyramidal side effects) (Aberg K, 2009, 17 SNPs) Response to antipsychotic therapy (extrapyramidal side effects) (Drago A, 2011, 1 SNP) Response to antipsychotic treatment (57 SNPs from 5 studies) Response to antipsychotic treatment (Adkins DE, 2010, 37 SNPs) Response to antipsychotic treatment (Alkelai A, 2009, 1 SNP) Response to antipsychotic treatment (Clark SL, 2012, 8 SNPs) Response to antipsychotic treatment (McClay JL, 2009, 9 SNPs) Response to antipsychotic treatment (McClay JL, 2010, 2 SNPs) Response to antipsychotic treatment in schizophrenia (reasoning) (McClay JL, 2010, 10 SNPs) Response to antipsychotic treatment in schizophrenia (working memory) (McClay JL, 2010, 11 SNPs) Response to chemotherapy in breast cancer (hypertension) (bevacizumab) (Schneider BP, 2014, 3 SNPs) Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab) (Schneider BP, 2014, 13 SNPs) Response to cholinesterase inhibitors in Alzheimer's disease (Martinelli-Boneschi F, 2013, 3 SNPs) Response to citalopram treatment (24 SNPs from 2 studies) Response to citalopram treatment (Adkins DE, 2012, 17 SNPs) Response to citalopram treatment (Garriock HA, 2009, 7 SNPs) Response to clopidogrel therapy (Shuldiner AR, 2009, 1 SNP) Response to cytadine analogues (cytosine arabinoside) (Li L, 2014, 22 SNPs) Response to cytidine analogues (gemcitabine) (Li L, 2014, 10 SNPs) Response to dabigatran etexilate treatment (Pare G, 2013, 2 SNPs) Response to Dalcetrapib treatment in acute coronary syndrome (Tardif JC, 2015, 1 SNP) Response to diuretic therapy (Turner ST, 2008, 3 SNPs) Response to diuretic therapy in hypertension (Turner ST, 2013, 1 SNP) Response to efavirenz-containing treatment in HIV 1 infection (virologic failure) (Lehmann DS, 2015, 35 SNPs) Response to fenofibrate (adiponectin levels) (Aslibekyan S, 2012, 12 SNPs) Response to fenofibrate (Frazier-Wood AC, 2012, 10 SNPs) Response to gemcitabine in pancreatic cancer (5 SNPs from 2 studies) Response to gemcitabine in pancreatic cancer (Innocenti F, 2011, 3 SNPs) Response to gemcitabine in pancreatic cancer (Kiyotani K, 2012, 2 SNPs) Response to haloperidol in psychosis (Drago A, 2014, 2 SNPs) Response to hepatitis C treatment (16 SNPs from 6 studies) Response to hepatitis C treatment (Ge D, 2009, 3 SNPs) Response to hepatitis C treatment (Lange CM, 2011, 9 SNPs) Response to hepatitis C treatment (Ochi H, 2011, 1 SNP) Response to hepatitis C treatment (Suppiah V, 2009, 1 SNP) Response to hepatitis C treatment (Tanaka Y, 2009, 1 SNP) Response to hepatitis C treatment (Tanaka Y, 2011, 4 SNPs) Response to iloperidone treatment (QT prolongation) (Volpi S, 2008, 6 SNPs) Response to inhaled corticosteroid treatment in asthma (percentage change of FEV1) (Park TJ, 2014, 21 SNPs) Response to interferon beta therapy (Weber F, 2011, 2 SNPs) Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer (Han JY, 2013, 7 SNPs) Response to irinotecan in non-small-cell lung cancer (Han JY, 2012, 2 SNPs) Response to metformin (Florez JC, 2011, 1 SNP) Response to metformin in type 2 diabetes (glycemic) (Zhou K, 2010, 1 SNP) Response to methotrexate in juvenile idiopathic arthritis (Cobb J, 2014, 18 SNPs) Response to methotrexate in rheumatoid arthritis (Senapati S, 2014, 2 SNPs) Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure) (Mick E, 2010, 7 SNPs) Response to mTOR inhibitor (everolimus) (Jiang J, 2013, 8 SNPs) Response to mTOR inhibitor (rapamycin) (Jiang J, 2013, 5 SNPs) Response to platinum-based agents (Won HH, 2011, 3 SNPs) Response to platinum-based chemotherapy (carboplatin) (Wheeler, 2011, 18 SNPs) Response to platinum-based chemotherapy (cisplatin) (Wheeler, 2011, 21 SNPs) Response to platinum-based chemotherapy in non-small-cell lung cancer (6 SNPs from 2 studies) Response to platinum-based chemotherapy in non-small-cell lung cancer (Hu L, 2012, 5 SNPs) Response to platinum-based chemotherapy in non-small-cell lung cancer (Wu X, 2011, 1 SNP) Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity) (Nelson D, 2014, 1 SNP) Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels) (Nelson D, 2014, 2 SNPs) Response to radiotherapy in cancer (late toxicity) (Barnett GC, 2014, 10 SNPs) Response to radiotherapy in prostate cancer (toxicity) (Fachal L, 2014, 1 SNP) Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) (Ji Y, 2014, 15 SNPs) Response to simvastatin treatment (PCSK9 protein level change) (Theusch E, 2014, 7 SNPs) Response to statin therapy (38 SNPs from 3 studies) Response to statin therapy (Barber MJ, 2010, 36 SNPs) Response to statin therapy (Deshmukh HA, 2012, 1 SNP) Response to statin therapy (LDL-C) (Chasman DI, 2012, 8 SNPs) Response to statin therapy (Link E, 2008, 1 SNP) Response to statins (LDL cholesterol change) (Postmus I, 2014, 6 SNPs) Response to tamoxifen in breast cancer (Kiyotani K, 2011, 1 SNP) Response to taxane treatment (docetaxel) (Niu N, 2012, 16 SNPs) Response to taxane treatment (placlitaxel) (Niu N, 2012, 13 SNPs) Response to temozolomide (Brown CC, 2012, 1 SNP) Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine) (Heap GA, 2014, 1 SNP) Response to TNF antagonist treatment (Liu C, 2008, 8 SNPs) Response to TNF-alpha inhibitors in rheumatoid arthritis (Krintel SB, 2012, 8 SNPs) Response to tocilizumab in rheumatoid arthritis (Wang J, 2012, 28 SNPs) Response to treatment for acute lymphoblastic leukemia (Yang JJ, 2009, 12 SNPs) Response to Vitamin E supplementation (Major JM, 2012, 8 SNPs) Resting heart rate (11 SNPs from 3 studies) Resting heart rate (Deo R, 2012, 2 SNPs) Resting heart rate (Eijgelsheim M, 2010, 10 SNPs) Resting heart rate (Mezzavilla M, 2014, 2 SNPs) Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry) (McDonald ML, 2014, 2 SNPs) Restless legs syndrome (6 SNPs from 4 studies) Restless legs syndrome (Schormair B, 2008, 2 SNPs) Restless legs syndrome (Stefansson H, 2007, 1 SNP) Restless legs syndrome (Winkelmann J, 2007, 3 SNPs) Restless legs syndrome (Winkelmann J, 2011, 6 SNPs) Retinal arteriolar caliber (Sim X, 2013, 2 SNPs) Retinal vascular caliber (Ikram MK, 2010, 5 SNPs) Retinol levels (Mondul AM, 2011, 2 SNPs) Retinopathy in non-diabetics (Jensen RA, 2013, 11 SNPs) Rhegmatogenous retinal detachment (Kirin M, 2013, 4 SNPs) Rheumatoid arthritis (177 SNPs from 18 studies) Rheumatoid arthritis (ACPA-negative) (Bossini-Castillo L, 2014, 6 SNPs) Rheumatoid arthritis (Freudenberg J, 2011, 5 SNPs) Rheumatoid arthritis (Gregersen PK, 2009, 5 SNPs) Rheumatoid arthritis (Hu HJ, 2011, 1 SNP) Rheumatoid arthritis (Jiang L, 2014, 15 SNPs) Rheumatoid arthritis (Julia A, 2008, 2 SNPs) Rheumatoid arthritis (Kochi Y, 2010, 4 SNPs) Rheumatoid arthritis (Myouzen K, 2012, 2 SNPs) Rheumatoid arthritis (Negi S, 2013, 2 SNPs) Rheumatoid arthritis (Okada Y, 2012, 15 SNPs) Rheumatoid arthritis (Okada Y, 2013, 166 SNPs) Rheumatoid arthritis (Orozco G, 2014, 8 SNPs) Rheumatoid arthritis (Padyukov L, 2010, 16 SNPs) Rheumatoid arthritis (Plenge RM, 2007, 2 SNPs) Rheumatoid arthritis (Plenge RM, 2007, 3 SNPs) Rheumatoid arthritis (Raychaudhuri S, 2008, 9 SNPs) Rheumatoid arthritis (Stahl EA, 2010, 29 SNPs) Rheumatoid arthritis (Terao C, 2011, 3 SNPs) Rheumatoid arthritis (WTCCC, 2007, 7 SNPs) Ribavirin-induced anemia (Ochi H, 2010, 1 SNP) RR interval (heart rate) (Marroni F, 2009, 20 SNPs) Sagittal craniosynostosis (Justice CM, 2012, 2 SNPs) Sarcoidosis (3 SNPs from 2 studies) Sarcoidosis (Fischer A, 2012, 1 SNP) Sarcoidosis (Hofmann S, 2012, 2 SNPs) Schizophrenia (117 SNPs from 25 studies) Schizophrenia (Aberg KA, 2013, 13 SNPs) Schizophrenia (age at onset) (Wang, 2011, 2 SNPs) Schizophrenia (Alkelai A, 2011, 2 SNPs) Schizophrenia (Athanasiu L, 2010, 3 SNPs) Schizophrenia (Bergen SE, 2012, 15 SNPs) Schizophrenia (Betcheva ET, 2012, 1 SNP) Schizophrenia (Borglum AD, 2013, 3 SNPs) Schizophrenia (cytomegalovirus infection interaction) (Borglum AD, 2013, 1 SNP) Schizophrenia (Fanous AH, 2012, 16 SNPs) Schizophrenia (Irish Schizophrenia Genomics Consortium & the Wellcome Trust Case Control Consortium 2, 2012, 2 SNPs) Schizophrenia (Kirov G, 2008, 1 SNP) Schizophrenia (Lencz T, 2007, 1 SNP) Schizophrenia (Lencz T, 2013, 1 SNP) Schizophrenia (Levinson DF, 2012, 11 SNPs) Schizophrenia (Ma X, 2011, 1 SNP) Schizophrenia (negative symptoms) (Xu C, 2013, 3 SNPs) Schizophrenia (O'Donovan MC, 2008, 3 SNPs) Schizophrenia (Purcell SM, 2009, 4 SNPs) Schizophrenia (Ripke S, 2011, 25 SNPs) Schizophrenia (Ripke S, 2013, 27 SNPs) Schizophrenia (Ripke S, 2014, 98 SNPs) Schizophrenia (Shi J, 2009, 2 SNPs) Schizophrenia (Shi Y, 2011, 2 SNPs) Schizophrenia (Shifman S, 2008, 1 SNP) Schizophrenia (Stefansson H, 2009, 7 SNPs) Schizophrenia (Sullivan PF, 2008, 6 SNPs) Schizophrenia (treatment resistant) (3 SNPs from 2 studies) Schizophrenia (treatment resistant) (Li J, 2014, 1 SNP) Schizophrenia (treatment resistant) (Liou YJ, 2012, 2 SNPs) Schizophrenia (Wong EH, 2013, 1 SNP) Schizophrenia (Yue WH, 2011, 2 SNPs) Schizophrenia or bipolar disorder (Ruderfer DM, 2013, 12 SNPs) Schizophrenia, bipolar disorder and depression (combined) (Huang J, 2010, 5 SNPs) Schizophrenia, schizoaffective disorder or bipolar disorder (Sleiman P, 2013, 5 SNPs) Sclerosing cholangitis and ulcerative colitis (combined) (Ellinghaus D, 2012, 2 SNPs) Scoliosis (3 SNPs from 2 studies) Scoliosis (Kou I, 2013, 2 SNPs) Scoliosis (Takahashi Y, 2011, 1 SNP) Seasonality (Byrne EM, 2014, 8 SNPs) Select biomarker traits (Benjamin EJ, 2007, 21 SNPs) Self-employment (van der Loos MJ, 2013, 2 SNPs) Self-rated health (Mosing MA, 2010, 10 SNPs) Self-reported allergy (Hinds DA, 2013, 35 SNPs) Sensory disturbances after bilateral sagittal split ramus osteotomy (Kobayashi D, 2013, 7 SNPs) Sepsis from pneumonia (survival) (Rautanen A, 2014, 2 SNPs) Serum albumin level (Franceschini N, 2012, 16 SNPs) Serum alkaline phosphatase levels (Li J, 2013, 4 SNPs) Serum ceruloplasmin levels (Tang WH, 2011, 1 SNP) Serum dimethylarginine levels (asymmetric/symetric ratio) (Seppala I, 2013, 24 SNPs) Serum ferritin levels (Liao M, 2014, 1 SNP) Serum IgA levels (Viktorin A, 2014, 1 SNP) Serum IgE levels (Pino-Yanes M, 2014, 2 SNPs) Serum lipase activity (Weiss FU, 2014, 2 SNPs) Serum metabolite levels (Yu B, 2014, 19 SNPs) Serum prostate-specific antigen levels (Gudmundsson J, 2010, 7 SNPs) Serum protein levels (sST2) (Ho JE, 2013, 14 SNPs) Serum selenium levels (Gong J, 2013, 4 SNPs) Serum tamsulosin hydrochloride concentration (Takata R, 2012, 4 SNPs) Serum thyroid-stimulating hormone levels (19 SNPs from 2 studies) Serum thyroid-stimulating hormone levels (Malinowski JR, 2014, 18 SNPs) Serum thyroid-stimulating hormone levels (Zhan M, 2014, 4 SNPs) Serum total protein level (Franceschini N, 2012, 12 SNPs) Serum uric acid levels (4 SNPs from 3 studies) Serum uric acid levels (Sulem P, 2011, 3 SNPs) Serum uric acid levels (Voruganti VS, 2013, 2 SNPs) Serum uric acid levels (Yang B, 2014, 4 SNPs) Serum VEGFR2 concentration (Maitland ML, 2014, 1 SNP) Serum vitamin D-binding protein levels (Moy KA, 2014, 3 SNPs) Sex hormone-binding globulin levels (36 SNPs from 2 studies) Sex hormone-binding globulin levels (Coviello AD, 2012, 30 SNPs) Sex hormone-binding globulin levels (Prescott J, 2012, 8 SNPs) Sexual dimorphism in anthropometric traits (Randall JC, 2013, 10 SNPs) Sexual dysfunction (female) (Burri A, 2012, 3 SNPs) Sexual dysfunction (SSRI/SNRI-related) (Kurose K, 2012, 5 SNPs) Shingles (Crosslin DR, 2014, 2 SNPs) Sickle cell anemia (haemolysis) (Milton JN, 2013, 4 SNPs) Sjögren's syndrome (Li Y, 2013, 5 SNPs) Skin pigmentation (Stokowski RP, 2007, 3 SNPs) Skin sensitivity to sun (4 SNPs from 2 studies) Skin sensitivity to sun (Sulem P, 2007, 2 SNPs) Skin sensitivity to sun (Sulem P, 2008, 2 SNPs) Sleep depth (Byrne EM, 2013, 2 SNPs) Sleep duration (20 SNPs from 2 studies) Sleep duration (Byrne EM, 2013, 7 SNPs) Sleep duration (Gottlieb DJ, 2014, 13 SNPs) Sleep quality (Byrne EM, 2013, 7 SNPs) Sleep time (Byrne EM, 2013, 5 SNPs) Sleep-related phenotypes (Gottlieb DJ, 2007, 5 SNPs) Small-cell lung cancer (survival) (Wu C, 2010, 1 SNP) Smoking behavior (38 SNPs from 7 studies) Smoking behavior (Caporaso N, 2009, 21 SNPs) Smoking behavior (David SP, 2012, 5 SNPs) Smoking behavior (Kumasaka N, 2012, 3 SNPs) Smoking behavior (Liu JZ, 2010, 1 SNP) Smoking behavior (The Tobacco and Genetics Consortium, 2010, 5 SNPs) Smoking behavior (Thorgeirsson TE, 2010, 5 SNPs) Smoking behavior (Yoon D, 2011, 6 SNPs) Smoking cessation (5 SNPs from 2 studies) Smoking cessation (Argos M, 2014, 4 SNPs) Smoking cessation (Uhl GR, 2010, 1 SNP) Smoking cessation in chronic obstructive pulmonary disease (Siedlinski M, 2011, 8 SNPs) Smoking initiation (Argos M, 2014, 27 SNPs) Smoking quantity (Argos M, 2014, 8 SNPs) Smooth-surface caries (42 SNPs from 2 studies) Smooth-surface caries (Zeng Z, 2013, 11 SNPs) Smooth-surface caries (Zeng Z, 2014, 31 SNPs) Social autistic-like traits (Jones RM, 2013, 6 SNPs) Social communication problems (21 SNPs from 2 studies) Social communication problems (St Pourcain B, 2013, 4 SNPs) Social communication problems (St Pourcain B, 2014, 17 SNPs) Soluble E-selectin levels (Paterson AD, 2009, 1 SNP) Soluble ICAM-1 (3 SNPs from 2 studies) Soluble ICAM-1 (Pare G, 2008, 4 SNPs) Soluble ICAM-1 (Pare G, 2011, 3 SNPs) Soluble leptin receptor levels (Sun Q, 2010, 1 SNP) Soluble levels of adhesion molecules (Barbalic M, 2010, 5 SNPs) Speech perception in dyslexia (Roeske D, 2009, 2 SNPs) Sphingolipid levels (10 SNPs from 2 studies) Sphingolipid levels (Demirkan A, 2012, 10 SNPs) Sphingolipid levels (Hicks AA, 2009, 5 SNPs) Spine bone size (Deng FY, 2012, 1 SNP) Spontaneous preterm birth (preterm birth) (Zhang H, 2015, 5 SNPs) Spontaneous preterm birth (preterm delivery) (Zhang H, 2015, 2 SNPs) Squamous cell carcinoma (Dong J, 2013, 1 SNP) Staphylococcus aureus infection (Ye Z, 2014, 4 SNPs) Stearic acid (18:0) plasma levels (Wu JH, 2013, 11 SNPs) Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) (Tohkin M, 2011, 1 SNP) Stroke (6 SNPs from 3 studies) Stroke (Bellenguez C, 2012, 1 SNP) Stroke (Ikram MA, 2009, 1 SNP) Stroke (ischemic) (8 SNPs from 3 studies) Stroke (ischemic) (Gretarsdottir S, 2008, 1 SNP) Stroke (ischemic) (Holliday EG, 2012, 1 SNP) Stroke (ischemic) (Traylor M, 2012, 8 SNPs) Stroke (Matarin M, 2007, 4 SNPs) Stroke (pediatric) (Arning A, 2012, 4 SNPs) Subclinical atherosclerosis traits (other) (O'Donnell CJ, 2007, 8 SNPs) Subcutaneous adipose tissue (Fox CS, 2012, 39 SNPs) Substance dependence (Chen X, 2011, 1 SNP) Sudden cardiac arrest (49 SNPs from 2 studies) Sudden cardiac arrest (Aouizerat BE, 2011, 49 SNPs) Sudden cardiac arrest (Arking DE, 2011, 1 SNP) Suicidal ideation (Perroud N, 2010, 4 SNPs) Suicidal ideation in depression or bipolar disorder (Mullins N, 2014, 1 SNP) Suicide attempts in bipolar disorder (Willour VL, 2011, 3 SNPs) Suicide attempts in depression or bipolar disorder (Mullins N, 2014, 3 SNPs) Suicide in bipolar disorder (Zai CC, 2014, 4 SNPs) Suicide risk (Perlis RH, 2010, 4 SNPs) Sunburns (Zhang M, 2013, 4 SNPs) Superior frontal gyrus grey matter volume (Hashimoto R, 2014, 11 SNPs) Symmetrical dimethylarginine levels (30 SNPs from 2 studies) Symmetrical dimethylarginine levels (Luneburg N, 2014, 1 SNP) Symmetrical dimethylarginine levels (Seppala I, 2013, 30 SNPs) Systemic lupus erythematosus (68 SNPs from 12 studies) Systemic lupus erythematosus (Armstrong DL, 2014, 22 SNPs) Systemic lupus erythematosus (Chung SA, 2011, 24 SNPs) Systemic lupus erythematosus (Graham RR, 2008, 8 SNPs) Systemic lupus erythematosus (Han JW, 2009, 18 SNPs) Systemic lupus erythematosus (Harley JB, 2008, 6 SNPs) Systemic lupus erythematosus (Hom G, 2008, 9 SNPs) Systemic lupus erythematosus (Kozyrev SV, 2008, 1 SNP) Systemic lupus erythematosus (Lee YH, 2012, 5 SNPs) Systemic lupus erythematosus (Okada Y, 2012, 2 SNPs) Systemic lupus erythematosus (Yang J, 2010, 1 SNP) Systemic lupus erythematosus (Yang W, 2010, 2 SNPs) Systemic lupus erythematosus (Yang W, 2012, 34 SNPs) Systemic lupus erythematosus and Systemic sclerosis (Martin JE, 2013, 20 SNPs) Systemic sclerosis (12 SNPs from 3 studies) Systemic sclerosis (Allanore Y, 2011, 7 SNPs) Systemic sclerosis (Gorlova O, 2011, 18 SNPs) Systemic sclerosis (Radstake TR, 2010, 4 SNPs) Systolic blood pressure (29 SNPs from 4 studies) Systolic blood pressure (alcohol consumption interaction) (Simino J, 2013, 11 SNPs) Systolic blood pressure (Ehret GB, 2011, 20 SNPs) Systolic blood pressure (Levy D, 2009, 7 SNPs) Systolic blood pressure (Lu X, 2014, 15 SNPs) Systolic blood pressure (Newton-Cheh C, 2009, 3 SNPs) Systolic blood pressure in sickle cell anemia (Bhatnagar P, 2013, 10 SNPs) Tanning (10 SNPs from 2 studies) Tanning (Nan H, 2009, 10 SNPs) Tanning (Zhang M, 2013, 5 SNPs) Tardive dyskinesia (Tanaka S, 2011, 1 SNP) Telomere length (24 SNPs from 11 studies) Telomere length (Codd V, 2010, 1 SNP) Telomere length (Codd V, 2013, 3 SNPs) Telomere length (Gu J, 2011, 4 SNPs) Telomere length (Lee JH, 2014, 8 SNPs) Telomere length (Levy D, 2010, 4 SNPs) Telomere length (Liu Y, 2014, 2 SNPs) Telomere length (Mangino M, 2009, 1 SNP) Telomere length (Mangino M, 2012, 4 SNPs) Telomere length (Pooley KA, 2013, 1 SNP) Telomere length (Prescott J, 2011, 1 SNP) Telomere length (Saxena R, 2014, 2 SNPs) Temperament (bipolar disorder) (Greenwood TA, 2012, 13 SNPs) Temperament (Service SK, 2012, 16 SNPs) Temporomandibular joint disorders (Yamaguchi T, 2013, 1 SNP) Testicular cancer (3 SNPs from 2 studies) Testicular cancer (Kanetsky PA, 2009, 1 SNP) Testicular cancer (Kanetsky PA, 2011, 2 SNPs) Testicular germ cell cancer (Turnbull C, 2010, 6 SNPs) Testicular germ cell tumor (19 SNPs from 3 studies) Testicular germ cell tumor (Chung CC, 2013, 11 SNPs) Testicular germ cell tumor (Rapley EA, 2009, 6 SNPs) Testicular germ cell tumor (Ruark E, 2013, 15 SNPs) Testosterone levels (7 SNPs from 2 studies) Testosterone levels (Ohlsson C, 2011, 2 SNPs) Testosterone levels (Prescott J, 2012, 5 SNPs) Tetralogy of Fallot (Cordell HJ, 2013, 6 SNPs) Thiazide-induced adverse metabolic effects in hypertensive patients (Del-Aguila JL, 2013, 59 SNPs) Thoracic aortic aneurysms and dissections (Lemaire SA, 2011, 1 SNP) Thrombin generation potential phenotypes (Rocanin-Arjo A, 2013, 4 SNPs) Thyroid cancer (4 SNPs from 3 studies) Thyroid cancer (Gudmundsson J, 2009, 2 SNPs) Thyroid cancer (Gudmundsson J, 2012, 3 SNPs) Thyroid cancer (Kohler A, 2013, 2 SNPs) Thyroid cancer (Papillary, radiation-related) (Takahashi M, 2010, 1 SNP) Thyroid function (Rawal R, 2012, 4 SNPs) Thyroid hormone levels (Porcu E, 2013, 60 SNPs) Thyroid peroxidase antibody levels (Medici M, 2014, 5 SNPs) Thyroid peroxidase antibody positivity (9 SNPs from 2 studies) Thyroid peroxidase antibody positivity (Kwak SH, 2014, 2 SNPs) Thyroid peroxidase antibody positivity (Medici M, 2014, 9 SNPs) Thyroid stimulating hormone (4 SNPs from 2 studies) Thyroid stimulating hormone (Arnaud-Lopez L, 2008, 1 SNP) Thyroid stimulating hormone (Hwang SJ, 2007, 3 SNPs) Thyroid volume (Teumer A, 2011, 8 SNPs) Thyrotoxic hypokalemic periodic paralysis (1 SNP from 2 studies) Thyrotoxic hypokalemic periodic paralysis (Cheung CL, 2012, 1 SNP) Thyrotoxic hypokalemic periodic paralysis (Jongjaroenprasert W, 2012, 1 SNP) Toenail selenium levels (Cornelis MC, 2014, 16 SNPs) Tonometry (Levy D, 2007, 13 SNPs) Tooth agenesis (mandibular third molar) (Haga S, 2013, 2 SNPs) Tooth agenesis (third molar) (Haga S, 2013, 1 SNP) Total bilirubin levels in HIV-1 infection (Moore CB, 2015, 11 SNPs) Total ventricular volume (Furney SJ, 2010, 19 SNPs) Tourette syndrome (Scharf JM, 2012, 7 SNPs) Tourette's syndrome or obsessive-compulsive disorder (Yu D, 2014, 15 SNPs) Trans fatty acid levels (Mozaffarian D, 2014, 131 SNPs) Treatment response for severe sepsis (Man M, 2012, 8 SNPs) Triglycerides (48 SNPs from 15 studies) Triglycerides (Aulchenko YS, 2008, 8 SNPs) Triglycerides (Coram MA, 2013, 7 SNPs) Triglycerides (Kamatani Y, 2010, 6 SNPs) Triglycerides (Kathiresan S, 2008, 11 SNPs) Triglycerides (Kathiresan S, 2008, 9 SNPs) Triglycerides (Kim YJ, 2011, 5 SNPs) Triglycerides (Ko A, 2014, 8 SNPs) Triglycerides (Kooner JS, 2008, 4 SNPs) Triglycerides (Pollin TI, 2008, 1 SNP) Triglycerides (Saxena R, 2007, 5 SNPs) Triglycerides (Tan A, 2011, 3 SNPs) Triglycerides (Teslovich TM, 2010, 32 SNPs) Triglycerides (Waterworth DM, 2010, 11 SNPs) Triglycerides (Willer CJ, 2008, 9 SNPs) Triglycerides (Willer CJ, 2013, 41 SNPs) Triglycerides-Blood Pressure (TG-BP) (Kraja AT, 2011, 6 SNPs) Tuberculosis (39 SNPs from 3 studies) Tuberculosis (Chimusa ER, 2013, 27 SNPs) Tuberculosis (Thye T, 2010, 14 SNPs) Tuberculosis (Thye T, 2012, 1 SNP) Tumor biomarkers (He M, 2013, 11 SNPs) Two-hour glucose challenge (Saxena R, 2010, 5 SNPs) Type 1 diabetes (55 SNPs from 10 studies) Type 1 diabetes (Barrett JC, 2009, 38 SNPs) Type 1 diabetes (Bradfield JP, 2011, 9 SNPs) Type 1 diabetes (Cooper JD, 2008, 14 SNPs) Type 1 diabetes (Grant SF, 2008, 5 SNPs) Type 1 diabetes (Hakonarson H, 2007, 4 SNPs) Type 1 diabetes (Hakonarson H, 2008, 1 SNP) Type 1 diabetes (Huang J, 2012, 2 SNPs) Type 1 diabetes (Todd JA, 2007, 12 SNPs) Type 1 diabetes (Wallace C, 2009, 2 SNPs) Type 1 diabetes (WTCCC, 2007, 10 SNPs) Type 1 diabetes autoantibodies (Plagnol V, 2011, 23 SNPs) Type 1 diabetes nephropathy (Sandholm N, 2012, 11 SNPs) Type 2 diabetes (135 SNPs from 40 studies) Type 2 diabetes (Al Safar HS, 2013, 1 SNP) Type 2 diabetes (Below JE, 2011, 1 SNP) Type 2 diabetes (Cho YS, 2011, 10 SNPs) Type 2 diabetes (Cui B, 2011, 2 SNPs) Type 2 diabetes (dietary heme iron intake interaction) (Pasquale LR, 2013, 4 SNPs) Type 2 diabetes (Ghassibe-Sabbagh M, 2014, 6 SNPs) Type 2 diabetes (Hanson RL, 2013, 2 SNPs) Type 2 diabetes (Hara K, 2013, 16 SNPs) Type 2 diabetes (Huang J, 2012, 1 SNP) Type 2 diabetes (Imamura M, 2012, 4 SNPs) Type 2 diabetes (Kho AN, 2011, 1 SNP) Type 2 diabetes (Kooner JS, 2011, 6 SNPs) Type 2 diabetes (Lettre G, 2011, 2 SNPs) Type 2 diabetes (Li H, 2012, 10 SNPs) Type 2 diabetes (Ma RC, 2013, 1 SNP) Type 2 diabetes (Mahajan A, 2014, 62 SNPs) Type 2 diabetes (Ng MC, 2014, 20 SNPs) Type 2 diabetes (Palmer ND, 2012, 4 SNPs) Type 2 diabetes (Parra EJ, 2011, 5 SNPs) Type 2 diabetes (Perry JR, 2012, 12 SNPs) Type 2 diabetes (Qi L, 2010, 1 SNP) Type 2 diabetes (Salonen JT, 2007, 2 SNPs) Type 2 diabetes (Saxena R, 2007, 8 SNPs) Type 2 diabetes (Saxena R, 2013, 17 SNPs) Type 2 diabetes (Scott LJ, 2007, 10 SNPs) Type 2 diabetes (Shu XO, 2010, 4 SNPs) Type 2 diabetes (Sim X, 2011, 17 SNPs) Type 2 diabetes (Sladek R, 2007, 3 SNPs) Type 2 diabetes (Steinthorsdottir V, 2007, 3 SNPs) Type 2 diabetes (Tabassum R, 2012, 6 SNPs) Type 2 diabetes (Takeuchi F, 2009, 7 SNPs) Type 2 diabetes (Timpson NJ, 2008, 8 SNPs) Type 2 diabetes (Tsai FJ, 2010, 3 SNPs) Type 2 diabetes (Unoki H, 2008, 3 SNPs) Type 2 diabetes (Voight BF, 2010, 26 SNPs) Type 2 diabetes (Williams AL, 2013, 4 SNPs) Type 2 diabetes (WTCCC, 2007, 7 SNPs) Type 2 diabetes (Yamauchi T, 2010, 1 SNP) Type 2 diabetes (Yasuda K, 2008, 1 SNP) Type 2 diabetes (young onset) and obesity (Ma RC, 2014, 2 SNPs) Type 2 diabetes (Zeggini E, 2007, 10 SNPs) Type 2 diabetes (Zeggini E, 2008, 16 SNPs) Type 2 diabetes and other traits (Rung J, 2009, 6 SNPs) Type 2 diabetes nephropathy (6 SNPs from 2 studies) Type 2 diabetes nephropathy (Maeda S, 2007, 1 SNP) Type 2 diabetes nephropathy (McDonough CW, 2010, 5 SNPs) Ulcerative colitis (78 SNPs from 12 studies) Ulcerative colitis (Anderson CA, 2011, 47 SNPs) Ulcerative colitis (Asano K, 2009, 7 SNPs) Ulcerative colitis (Barrett JC, 2009, 13 SNPs) Ulcerative colitis (Franke A, 2008, 2 SNPs) Ulcerative colitis (Franke A, 2010, 6 SNPs) Ulcerative colitis (Haritunians T, 2010, 10 SNPs) Ulcerative colitis (Jostins L, 2012, 23 SNPs) Ulcerative colitis (Julià A, 2014, 9 SNPs) Ulcerative colitis (Juyal G, 2014, 5 SNPs) Ulcerative colitis (McGovern DP, 2010, 19 SNPs) Ulcerative colitis (Silverberg MS, 2009, 12 SNPs) Ulcerative colitis (Yang SK, 2013, 8 SNPs) Ulcerative colitis or Crohn's disease (Okada Y, 2011, 2 SNPs) Underweight status (Scannell Bryan M, 2014, 2 SNPs) Upper aerodigestive tract cancers (McKay JD, 2011, 5 SNPs) Urate levels (2 SNPs from 9 studies) Urate levels (Dehghan A, 2008, 3 SNPs) Urate levels (Doring A, 2008, 1 SNP) Urate levels (Kamatani Y, 2010, 5 SNPs) Urate levels (Kottgen A, 2012, 47 SNPs) Urate levels (Li S, 2007, 1 SNP) Urate levels (Tin A, 2011, 5 SNPs) Urate levels (Vitart V, 2008, 1 SNP) Urate levels (Wallace C, 2008, 1 SNP) Urate levels (Yang Q, 2010, 11 SNPs) Urgency urinary incontinence (Richter HE, 2014, 6 SNPs) Uric acid levels (30 SNPs from 5 studies) Uric acid levels (Charles BA, 2011, 12 SNPs) Uric acid levels (Karns R, 2012, 6 SNPs) Uric acid levels (Kolz M, 2009, 11 SNPs) Uric acid levels (Li WD, 2013, 6 SNPs) Uric acid levels (McArdle PF, 2008, 7 SNPs) Urinary albumin excretion (3 SNPs from 2 studies) Urinary albumin excretion (Boger CA, 2011, 1 SNP) Urinary albumin excretion (Hwang SJ, 2007, 2 SNPs) Urinary albumin excretion rate in type 1 diabetes (Sandholm N, 2014, 2 SNPs) Urinary bladder cancer (4 SNPs from 3 studies) Urinary bladder cancer (Kiemeney LA, 2008, 2 SNPs) Urinary bladder cancer (Kiemeney LA, 2010, 3 SNPs) Urinary bladder cancer (Rafnar T, 2014, 2 SNPs) Urinary metabolites (H-NMR features) (Rueedi R, 2014, 39 SNPs) Urinary metabolites (Suhre K, 2011, 5 SNPs) Urinary symptoms in response to radiotherapy in prostate cancer (Kerns SL, 2013, 1 SNP) Urinary uromodulin levels (Olden M, 2014, 5 SNPs) Uterine fibroids (Cha PC, 2011, 5 SNPs) Vaccine-related adverse events (Miller EK, 2011, 2 SNPs) Vascular brain injury (Beecham GW, 2014, 14 SNPs) Vascular dementia (Kim Y, 2011, 1 SNP) Vascular endothelial growth factor levels (Debette S, 2011, 4 SNPs) Vaspin levels (Breitfeld J, 2012, 1 SNP) Venous thromboembolism (8 SNPs from 4 studies) Venous thromboembolism (gene x gene interaction) (Greliche N, 2013, 74 SNPs) Venous thromboembolism (Germain M, 2011, 4 SNPs) Venous thromboembolism (Heit JA, 2012, 5 SNPs) Venous thromboembolism (Tang W, 2013, 8 SNPs) Venous thromboembolism (Tregouet DA, 2009, 1 SNP) Verbal declarative memory (Debette S, 2014, 43 SNPs) Vertical cup-disc ratio (21 SNPs from 2 studies) Vertical cup-disc ratio (Ramdas WD, 2010, 9 SNPs) Vertical cup-disc ratio (Springelkamp H, 2014, 18 SNPs) Very long-chain saturated fatty acid levels (fatty acid 20:0) (Lemaitre RN, 2014, 21 SNPs) Very long-chain saturated fatty acid levels (fatty acid 22:0) (Lemaitre RN, 2014, 11 SNPs) Very long-chain saturated fatty acid levels (fatty acid 24:0) (Lemaitre RN, 2014, 4 SNPs) Visceral adipose tissue adjusted for BMI (Fox CS, 2012, 44 SNPs) Visceral adipose tissue/subcutaneous adipose tissue ratio (Fox CS, 2012, 42 SNPs) Visceral fat (Fox CS, 2012, 39 SNPs) Vitamin B levels in ischemic stroke (Keene KL, 2014, 8 SNPs) Vitamin B12 levels (6 SNPs from 2 studies) Vitamin B12 levels (Hazra A, 2008, 1 SNP) Vitamin B12 levels (Lin X, 2012, 6 SNPs) Vitamin D insufficiency (Wang TJ, 2010, 3 SNPs) Vitamin D levels (9 SNPs from 3 studies) Vitamin D levels (Ahn J, 2010, 3 SNPs) Vitamin D levels (Anderson D, 2014, 11 SNPs) Vitamin D levels (Lasky-Su J, 2012, 1 SNP) Vitamin E levels (Major JM, 2011, 3 SNPs) Vitiligo (33 SNPs from 6 studies) Vitiligo (Birlea SA, 2009, 4 SNPs) Vitiligo (Jin Y, 2010, 10 SNPs) Vitiligo (Jin Y, 2011, 1 SNP) Vitiligo (Jin Y, 2012, 14 SNPs) Vitiligo (non-segmental) (Cheong KA, 2013, 1 SNP) Vitiligo (Quan C, 2010, 4 SNPs) Vitiligo (Tang XF, 2012, 4 SNPs) Vogt-Koyanagi-Harada syndrome (Hou S, 2014, 4 SNPs) Volumetric brain MRI (Seshadri S, 2007, 5 SNPs) vWF and FVIII levels (Antoni G, 2011, 11 SNPs) Waist circumference (24 SNPs from 4 studies) Waist circumference (Croteau-Chonka DC, 2010, 8 SNPs) Waist circumference (Fox CS, 2007, 2 SNPs) Waist circumference (Heard-Costa NL, 2009, 7 SNPs) Waist circumference (Liu CT, 2013, 7 SNPs) Waist Circumference - Triglycerides (WC-TG) (Kraja AT, 2011, 7 SNPs) Waist circumference and related phenotypes (Chambers JC, 2008, 4 SNPs) Waist-hip ratio (20 SNPs from 3 studies) Waist-hip ratio (Berndt SI, 2013, 4 SNPs) Waist-hip ratio (Heid IM, 2010, 16 SNPs) Waist-hip ratio (Liu CT, 2013, 6 SNPs) Waist-to-hip circumference ratio (interaction) (Velez Edwards DR, 2012, 14 SNPs) Warfarin maintenance dose (7 SNPs from 4 studies) Warfarin maintenance dose (Cha PC, 2010, 5 SNPs) Warfarin maintenance dose (Cooper GM, 2008, 3 SNPs) Warfarin maintenance dose (Perera MA, 2013, 1 SNP) Warfarin maintenance dose (Takeuchi F, 2009, 4 SNPs) Wegener's granulomatosis (Xie G, 2013, 6 SNPs) Weight (33 SNPs from 3 studies) Weight (Croteau-Chonka DC, 2010, 7 SNPs) Weight (Johansson A, 2009, 9 SNPs) Weight (Thorleifsson G, 2008, 17 SNPs) Weight loss (gastric bypass surgery) (12 SNPs from 2 studies) Weight loss (gastric bypass surgery) (Hatoum IJ, 2013, 5 SNPs) Weight loss (gastric bypass surgery) (Rinella ES, 2013, 7 SNPs) White blood cell count (16 SNPs from 5 studies) White blood cell count (Crosslin DR, 2011, 4 SNPs) White blood cell count (Kamatani Y, 2010, 5 SNPs) White blood cell count (Keller MF, 2014, 16 SNPs) White blood cell count (Nalls MA, 2011, 10 SNPs) White blood cell count (Reiner AP, 2011, 2 SNPs) White blood cell types (Okada Y, 2011, 20 SNPs) White matter hyperintensity burden (Fornage M, 2011, 2 SNPs) White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (Opherk C, 2014, 4 SNPs) White matter integrity (9 SNPs from 2 studies) White matter integrity (interaction) (Sprooten E, 2012, 6 SNPs) White matter integrity (Lopez LM, 2012, 2 SNPs) White matter integrity (Sprooten E, 2012, 7 SNPs) White matter microstructure (global fractional anisotropy) (Sprooten E, 2014, 5 SNPs) Wilms tumor (Turnbull C, 2012, 7 SNPs) Word reading (Luciano M, 2013, 15 SNPs) Yang-deficiency constitution (Yao SL, 2014, 1 SNP) YKL-40 levels (Ober C, 2008, 1 SNP)